Gene Symbol | Gene ID | Gene Info |
---|---|---|
RCOR1
|
ENSG00000089902.8 | REST corepressor 1 |
MTA3
|
ENSG00000057935.9 | metastasis associated 1 family member 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_42721370_42721657 | MTA3 | 196 | 0.601529 | 0.94 | 2.1e-04 | Click! |
chr2_42802517_42802668 | MTA3 | 6068 | 0.257633 | 0.82 | 6.4e-03 | Click! |
chr2_42800181_42800332 | MTA3 | 3732 | 0.292350 | 0.79 | 1.1e-02 | Click! |
chr2_42796432_42796800 | MTA3 | 92 | 0.978649 | 0.74 | 2.3e-02 | Click! |
chr2_42796086_42796237 | MTA3 | 275 | 0.936227 | 0.68 | 4.2e-02 | Click! |
chr14_103059953_103060104 | RCOR1 | 795 | 0.620390 | 0.89 | 1.1e-03 | Click! |
chr14_103070632_103070797 | RCOR1 | 11481 | 0.178402 | 0.80 | 1.0e-02 | Click! |
chr14_103058050_103058201 | RCOR1 | 873 | 0.579842 | 0.72 | 2.7e-02 | Click! |
chr14_103088050_103088201 | RCOR1 | 28892 | 0.152124 | 0.70 | 3.6e-02 | Click! |
chr14_103061345_103061577 | RCOR1 | 2228 | 0.284994 | 0.63 | 6.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr22_38392003_38392339 | 6.12 |
ENSG00000264505 |
. |
7370 |
0.1 |
chr17_48277708_48277975 | 5.70 |
COL1A1 |
collagen, type I, alpha 1 |
289 |
0.84 |
chr11_121351250_121351763 | 5.69 |
RP11-730K11.1 |
|
27784 |
0.21 |
chr19_52193071_52193310 | 5.52 |
ENSG00000207550 |
. |
2675 |
0.13 |
chr7_19156075_19156556 | 5.44 |
TWIST1 |
twist family bHLH transcription factor 1 |
980 |
0.47 |
chr5_131821382_131821819 | 5.35 |
IRF1 |
interferon regulatory factor 1 |
3737 |
0.16 |
chr16_68389761_68390217 | 5.27 |
SMPD3 |
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
14919 |
0.11 |
chr10_134365433_134366156 | 5.24 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
14151 |
0.21 |
chr8_97506971_97507442 | 5.18 |
SDC2 |
syndecan 2 |
970 |
0.67 |
chr22_42695306_42695687 | 5.07 |
TCF20 |
transcription factor 20 (AR1) |
44126 |
0.14 |
chr19_51228108_51228259 | 5.04 |
CLEC11A |
C-type lectin domain family 11, member A |
1403 |
0.27 |
chr5_176857919_176858519 | 4.97 |
GRK6 |
G protein-coupled receptor kinase 6 |
4364 |
0.11 |
chr15_48937816_48938257 | 4.75 |
FBN1 |
fibrillin 1 |
10 |
0.99 |
chr14_61189693_61189844 | 4.75 |
SIX4 |
SIX homeobox 4 |
1084 |
0.55 |
chrX_149108160_149108431 | 4.69 |
LINC00894 |
long intergenic non-protein coding RNA 894 |
79 |
0.95 |
chr20_62183766_62184103 | 4.66 |
C20orf195 |
chromosome 20 open reading frame 195 |
439 |
0.69 |
chr12_6740807_6741147 | 4.61 |
LPAR5 |
lysophosphatidic acid receptor 5 |
162 |
0.89 |
chr19_39894151_39894444 | 4.58 |
ZFP36 |
ZFP36 ring finger protein |
3156 |
0.1 |
chr19_43032810_43033477 | 4.57 |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
482 |
0.79 |
chr17_48278292_48278683 | 4.57 |
COL1A1 |
collagen, type I, alpha 1 |
506 |
0.68 |
chr7_42277184_42277379 | 4.54 |
GLI3 |
GLI family zinc finger 3 |
623 |
0.85 |
chr4_7043959_7044306 | 4.50 |
TADA2B |
transcriptional adaptor 2B |
506 |
0.46 |
chr1_3820226_3820752 | 4.34 |
C1orf174 |
chromosome 1 open reading frame 174 |
3640 |
0.21 |
chr1_151809574_151809991 | 4.34 |
C2CD4D |
C2 calcium-dependent domain containing 4D |
3251 |
0.1 |
chr8_145582513_145582761 | 4.32 |
SLC52A2 |
solute carrier family 52 (riboflavin transporter), member 2 |
13 |
0.86 |
chr7_19157255_19157514 | 4.31 |
TWIST1 |
twist family bHLH transcription factor 1 |
89 |
0.96 |
chr21_45230405_45230556 | 4.30 |
AP001053.11 |
|
238 |
0.92 |
chr3_157823749_157823966 | 4.27 |
SHOX2 |
short stature homeobox 2 |
18 |
0.74 |
chr4_81187912_81188421 | 4.23 |
FGF5 |
fibroblast growth factor 5 |
373 |
0.9 |
chr16_54320231_54320412 | 4.23 |
IRX3 |
iroquois homeobox 3 |
354 |
0.91 |
chr1_145575305_145575586 | 4.22 |
PIAS3 |
protein inhibitor of activated STAT, 3 |
121 |
0.93 |
chr11_72331841_72332069 | 4.18 |
ENSG00000251919 |
. |
855 |
0.48 |
chr2_227663405_227663664 | 4.18 |
IRS1 |
insulin receptor substrate 1 |
941 |
0.59 |
chr7_105711867_105712305 | 4.17 |
SYPL1 |
synaptophysin-like 1 |
26222 |
0.22 |
chr16_67571495_67571694 | 4.16 |
FAM65A |
family with sequence similarity 65, member A |
218 |
0.85 |
chr5_98105054_98105343 | 4.08 |
RGMB |
repulsive guidance molecule family member b |
199 |
0.95 |
chr4_169753476_169753760 | 4.04 |
PALLD |
palladin, cytoskeletal associated protein |
426 |
0.51 |
chr6_83073756_83074156 | 4.04 |
TPBG |
trophoblast glycoprotein |
5 |
0.99 |
chr1_53386842_53387121 | 4.02 |
ECHDC2 |
enoyl CoA hydratase domain containing 2 |
395 |
0.76 |
chr5_177543276_177543552 | 3.99 |
N4BP3 |
NEDD4 binding protein 3 |
2970 |
0.23 |
chr4_4388027_4388234 | 3.99 |
NSG1 |
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
135 |
0.97 |
chr11_62313084_62313252 | 3.97 |
AHNAK |
AHNAK nucleoprotein |
9 |
0.8 |
chr17_4542217_4542549 | 3.96 |
ALOX15 |
arachidonate 15-lipoxygenase |
794 |
0.48 |
chr22_37694628_37694892 | 3.91 |
CYTH4 |
cytohesin 4 |
11249 |
0.17 |
chr6_43701930_43702213 | 3.90 |
VEGFA |
vascular endothelial growth factor A |
35879 |
0.12 |
chr21_44835236_44835488 | 3.90 |
SIK1 |
salt-inducible kinase 1 |
11646 |
0.28 |
chr7_151130164_151130504 | 3.89 |
ENSG00000265810 |
. |
391 |
0.76 |
chr17_72984009_72984428 | 3.89 |
CDR2L |
cerebellar degeneration-related protein 2-like |
491 |
0.63 |
chr17_1618744_1618964 | 3.88 |
WDR81 |
WD repeat domain 81 |
963 |
0.33 |
chr17_4539926_4540256 | 3.88 |
ALOX15 |
arachidonate 15-lipoxygenase |
3086 |
0.15 |
chr22_39487886_39488384 | 3.88 |
RP4-742C19.12 |
|
544 |
0.68 |
chr4_141072389_141072607 | 3.87 |
MAML3 |
mastermind-like 3 (Drosophila) |
1625 |
0.44 |
chr8_57123328_57123484 | 3.83 |
PLAG1 |
pleiomorphic adenoma gene 1 |
432 |
0.68 |
chr12_30948813_30949034 | 3.81 |
CAPRIN2 |
caprin family member 2 |
41038 |
0.19 |
chr2_242801281_242801432 | 3.81 |
PDCD1 |
programmed cell death 1 |
296 |
0.83 |
chr16_2040564_2040867 | 3.80 |
SYNGR3 |
synaptogyrin 3 |
410 |
0.54 |
chr14_23306140_23306484 | 3.80 |
MMP14 |
matrix metallopeptidase 14 (membrane-inserted) |
209 |
0.85 |
chr11_121352230_121352444 | 3.80 |
RP11-730K11.1 |
|
28615 |
0.21 |
chr1_31214307_31214682 | 3.79 |
ENSG00000264773 |
. |
2415 |
0.24 |
chr4_775014_775218 | 3.75 |
RP11-440L14.1 |
|
502 |
0.7 |
chr17_38737904_38738640 | 3.72 |
CCR7 |
chemokine (C-C motif) receptor 7 |
16548 |
0.15 |
chr11_117882452_117882916 | 3.69 |
IL10RA |
interleukin 10 receptor, alpha |
25575 |
0.15 |
chr16_85588898_85589049 | 3.69 |
GSE1 |
Gse1 coiled-coil protein |
56042 |
0.12 |
chr11_1865277_1865556 | 3.69 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
3992 |
0.11 |
chr10_118501252_118501433 | 3.68 |
HSPA12A |
heat shock 70kDa protein 12A |
743 |
0.71 |
chr19_46474609_46474869 | 3.68 |
NOVA2 |
neuro-oncological ventral antigen 2 |
2065 |
0.22 |
chr12_53592478_53593243 | 3.68 |
ITGB7 |
integrin, beta 7 |
1367 |
0.28 |
chr9_135932298_135932581 | 3.67 |
GTF3C5 |
general transcription factor IIIC, polypeptide 5, 63kDa |
3133 |
0.17 |
chr1_25886898_25887280 | 3.67 |
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
17018 |
0.19 |
chr14_91859539_91859984 | 3.65 |
CCDC88C |
coiled-coil domain containing 88C |
23929 |
0.2 |
chr17_80259260_80259561 | 3.65 |
CD7 |
CD7 molecule |
16018 |
0.1 |
chr1_28586799_28587133 | 3.64 |
SESN2 |
sestrin 2 |
928 |
0.45 |
chr8_126442398_126442698 | 3.63 |
TRIB1 |
tribbles pseudokinase 1 |
15 |
0.98 |
chr8_144655209_144655539 | 3.62 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr22_45065075_45065405 | 3.62 |
PRR5 |
proline rich 5 (renal) |
647 |
0.75 |
chr17_3571236_3571438 | 3.62 |
TAX1BP3 |
Tax1 (human T-cell leukemia virus type I) binding protein 3 |
639 |
0.4 |
chr10_74089130_74089540 | 3.61 |
DNAJB12 |
DnaJ (Hsp40) homolog, subfamily B, member 12 |
15384 |
0.18 |
chr22_39146873_39147412 | 3.60 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
823 |
0.37 |
chr9_114361618_114361849 | 3.60 |
PTGR1 |
prostaglandin reductase 1 |
46 |
0.97 |
chr8_21907130_21907348 | 3.58 |
DMTN |
dematin actin binding protein |
579 |
0.63 |
chr9_29212913_29213411 | 3.58 |
ENSG00000215939 |
. |
324209 |
0.01 |
chr10_8102556_8102873 | 3.57 |
GATA3 |
GATA binding protein 3 |
5945 |
0.34 |
chr8_30242153_30242439 | 3.56 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
40 |
0.77 |
chrX_153597997_153598148 | 3.56 |
FLNA |
filamin A, alpha |
1579 |
0.2 |
chr3_185826094_185826337 | 3.56 |
ETV5 |
ets variant 5 |
118 |
0.97 |
chr9_137533446_137533714 | 3.54 |
COL5A1 |
collagen, type V, alpha 1 |
40 |
0.98 |
chr14_102002023_102002232 | 3.54 |
ENSG00000258498 |
. |
24632 |
0.17 |
chr15_90756571_90757151 | 3.53 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
8121 |
0.12 |
chr1_10964180_10964456 | 3.53 |
C1orf127 |
chromosome 1 open reading frame 127 |
43609 |
0.13 |
chr1_204430287_204430899 | 3.52 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
5881 |
0.2 |
chr17_80274023_80274286 | 3.51 |
CD7 |
CD7 molecule |
1274 |
0.31 |
chr14_24837393_24837740 | 3.51 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
19 |
0.94 |
chr1_86046764_86046989 | 3.48 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
432 |
0.82 |
chr1_26861688_26862188 | 3.47 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
4119 |
0.17 |
chr1_154297413_154297726 | 3.46 |
ATP8B2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
460 |
0.66 |
chr7_2549413_2549701 | 3.46 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
2606 |
0.23 |
chr1_154983545_154983845 | 3.46 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
3229 |
0.09 |
chr12_6570561_6570923 | 3.45 |
VAMP1 |
vesicle-associated membrane protein 1 (synaptobrevin 1) |
9069 |
0.09 |
chr21_43481615_43482274 | 3.45 |
UMODL1 |
uromodulin-like 1 |
1124 |
0.52 |
chr10_33624260_33624479 | 3.44 |
NRP1 |
neuropilin 1 |
363 |
0.91 |
chr3_3841565_3841901 | 3.44 |
LRRN1 |
leucine rich repeat neuronal 1 |
612 |
0.85 |
chr3_184080123_184080481 | 3.43 |
POLR2H |
polymerase (RNA) II (DNA directed) polypeptide H |
101 |
0.9 |
chr1_29450884_29451169 | 3.43 |
TMEM200B |
transmembrane protein 200B |
579 |
0.76 |
chr13_46425071_46425380 | 3.39 |
SIAH3 |
siah E3 ubiquitin protein ligase family member 3 |
646 |
0.8 |
chr11_125496038_125496275 | 3.39 |
CHEK1 |
checkpoint kinase 1 |
32 |
0.97 |
chr1_203270016_203270617 | 3.38 |
BTG2 |
BTG family, member 2 |
4348 |
0.2 |
chr19_7771578_7772024 | 3.38 |
FCER2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
4769 |
0.1 |
chr5_176799321_176799505 | 3.37 |
RGS14 |
regulator of G-protein signaling 14 |
5469 |
0.1 |
chr18_46066030_46066316 | 3.37 |
CTIF |
CBP80/20-dependent translation initiation factor |
186 |
0.96 |
chr1_202128079_202128502 | 3.36 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
829 |
0.53 |
chr7_420968_421342 | 3.36 |
AC187652.1 |
Protein LOC100996433 |
118237 |
0.05 |
chr17_72365067_72365427 | 3.36 |
GPR142 |
G protein-coupled receptor 142 |
1650 |
0.25 |
chr13_42622313_42622722 | 3.36 |
DGKH |
diacylglycerol kinase, eta |
372 |
0.88 |
chr19_11307886_11308089 | 3.35 |
KANK2 |
KN motif and ankyrin repeat domains 2 |
210 |
0.89 |
chr19_14184872_14185147 | 3.34 |
hsa-mir-1199 |
hsa-mir-1199 |
615 |
0.53 |
chr9_130546581_130547054 | 3.34 |
CDK9 |
cyclin-dependent kinase 9 |
1141 |
0.24 |
chr2_173322612_173322874 | 3.33 |
AC078883.3 |
|
7997 |
0.18 |
chr1_156123699_156124153 | 3.33 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
236 |
0.87 |
chr1_161993174_161993534 | 3.32 |
OLFML2B |
olfactomedin-like 2B |
76 |
0.98 |
chr15_70770026_70770327 | 3.32 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
224444 |
0.02 |
chr14_105642427_105642578 | 3.32 |
NUDT14 |
nudix (nucleoside diphosphate linked moiety X)-type motif 14 |
5138 |
0.18 |
chr2_145275512_145275663 | 3.32 |
ZEB2-AS1 |
ZEB2 antisense RNA 1 |
77 |
0.56 |
chr12_57111005_57111309 | 3.31 |
NACA |
nascent polypeptide-associated complex alpha subunit |
2227 |
0.21 |
chr1_26616916_26617250 | 3.31 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
10470 |
0.11 |
chr2_26204901_26205217 | 3.31 |
KIF3C |
kinesin family member 3C |
307 |
0.91 |
chr15_82337396_82337700 | 3.30 |
MEX3B |
mex-3 RNA binding family member B |
912 |
0.4 |
chr19_42463079_42463289 | 3.30 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr11_121352463_121352614 | 3.30 |
RP11-730K11.1 |
|
28816 |
0.21 |
chr20_56266492_56266875 | 3.30 |
PMEPA1 |
prostate transmembrane protein, androgen induced 1 |
203 |
0.96 |
chr16_56485728_56485939 | 3.29 |
NUDT21 |
nudix (nucleoside diphosphate linked moiety X)-type motif 21 |
278 |
0.56 |
chr7_917217_917368 | 3.29 |
GET4 |
golgi to ER traffic protein 4 homolog (S. cerevisiae) |
250 |
0.9 |
chr17_56409271_56409708 | 3.28 |
MIR142 |
microRNA 142 |
380 |
0.74 |
chr9_130966352_130966616 | 3.28 |
CIZ1 |
CDKN1A interacting zinc finger protein 1 |
178 |
0.83 |
chr4_8161119_8161320 | 3.28 |
ABLIM2 |
actin binding LIM protein family, member 2 |
660 |
0.74 |
chr11_76495133_76495321 | 3.28 |
TSKU |
tsukushi, small leucine rich proteoglycan |
35 |
0.95 |
chr12_96184490_96184641 | 3.28 |
NTN4 |
netrin 4 |
23 |
0.97 |
chr19_10663518_10663765 | 3.28 |
ENSG00000221410 |
. |
843 |
0.3 |
chr4_1753783_1753977 | 3.28 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
23749 |
0.13 |
chr16_67693468_67693710 | 3.27 |
ACD |
adrenocortical dysplasia homolog (mouse) |
263 |
0.79 |
chr7_150685880_150686039 | 3.27 |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
2124 |
0.2 |
chr17_8025338_8025489 | 3.27 |
HES7 |
hes family bHLH transcription factor 7 |
1989 |
0.15 |
chrX_49055708_49055990 | 3.26 |
SYP-AS1 |
SYP antisense RNA 1 |
424 |
0.54 |
chr1_154980745_154981008 | 3.26 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5581 |
0.08 |
chr19_51924575_51924989 | 3.25 |
SIGLEC10 |
sialic acid binding Ig-like lectin 10 |
3725 |
0.1 |
chr3_196668934_196669213 | 3.24 |
NCBP2 |
nuclear cap binding protein subunit 2, 20kDa |
175 |
0.91 |
chr13_44361106_44361257 | 3.24 |
ENOX1 |
ecto-NOX disulfide-thiol exchanger 1 |
137 |
0.98 |
chr1_107683429_107683828 | 3.24 |
NTNG1 |
netrin G1 |
33 |
0.99 |
chr14_24783456_24784225 | 3.24 |
LTB4R |
leukotriene B4 receptor |
66 |
0.91 |
chr12_671632_671826 | 3.23 |
B4GALNT3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
19430 |
0.13 |
chr17_72594997_72595277 | 3.22 |
CD300LD |
CD300 molecule-like family member d |
6715 |
0.13 |
chr3_127255754_127255970 | 3.22 |
TPRA1 |
transmembrane protein, adipocyte asscociated 1 |
43418 |
0.15 |
chr12_6742048_6742439 | 3.21 |
LPAR5 |
lysophosphatidic acid receptor 5 |
1428 |
0.21 |
chr2_27071961_27072112 | 3.21 |
DPYSL5 |
dihydropyrimidinase-like 5 |
660 |
0.72 |
chr17_43326217_43326729 | 3.21 |
CTD-2020K17.4 |
|
270 |
0.78 |
chr7_143059266_143059514 | 3.21 |
FAM131B |
family with sequence similarity 131, member B |
242 |
0.87 |
chr14_69286868_69287190 | 3.20 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
23839 |
0.18 |
chr16_56894069_56894239 | 3.20 |
ENSG00000207649 |
. |
1724 |
0.27 |
chr16_87905793_87906147 | 3.20 |
SLC7A5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
2876 |
0.24 |
chr3_47022966_47023797 | 3.19 |
CCDC12 |
coiled-coil domain containing 12 |
74 |
0.97 |
chr16_3006046_3006197 | 3.19 |
LA16c-321D4.2 |
|
1844 |
0.15 |
chr1_154298682_154298965 | 3.18 |
ATP8B2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
794 |
0.44 |
chr6_33544655_33545071 | 3.18 |
BAK1 |
BCL2-antagonist/killer 1 |
3118 |
0.17 |
chr2_12857216_12857660 | 3.18 |
TRIB2 |
tribbles pseudokinase 2 |
377 |
0.91 |
chr19_7741444_7741683 | 3.18 |
C19orf59 |
chromosome 19 open reading frame 59 |
49 |
0.93 |
chr11_67177814_67178291 | 3.18 |
CARNS1 |
carnosine synthase 1 |
5097 |
0.07 |
chr11_65313468_65313794 | 3.17 |
LTBP3 |
latent transforming growth factor beta binding protein 3 |
599 |
0.54 |
chr1_24117965_24118246 | 3.17 |
LYPLA2 |
lysophospholipase II |
377 |
0.76 |
chr1_154942964_154943148 | 3.16 |
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
54 |
0.93 |
chr5_474031_474382 | 3.16 |
ENSG00000225138 |
. |
855 |
0.37 |
chr3_18465405_18465909 | 3.16 |
SATB1 |
SATB homeobox 1 |
408 |
0.87 |
chr10_135078072_135078274 | 3.16 |
ADAM8 |
ADAM metallopeptidase domain 8 |
12181 |
0.1 |
chr1_200989461_200990085 | 3.15 |
KIF21B |
kinesin family member 21B |
2763 |
0.26 |
chr1_215255825_215256068 | 3.15 |
KCNK2 |
potassium channel, subfamily K, member 2 |
521 |
0.89 |
chr20_25023666_25023817 | 3.14 |
ACSS1 |
acyl-CoA synthetase short-chain family member 1 |
10402 |
0.2 |
chr17_30333890_30334183 | 3.14 |
LRRC37B |
leucine rich repeat containing 37B |
855 |
0.61 |
chr5_139028860_139029144 | 3.13 |
CXXC5 |
CXXC finger protein 5 |
484 |
0.83 |
chr15_40212284_40212453 | 3.13 |
GPR176 |
G protein-coupled receptor 176 |
58 |
0.96 |
chr19_55685507_55685658 | 3.12 |
SYT5 |
synaptotagmin V |
352 |
0.72 |
chr10_73723963_73724261 | 3.12 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
11 |
0.99 |
chr19_42051966_42052728 | 3.11 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
3539 |
0.21 |
chr7_142028801_142029083 | 3.10 |
PRSS3P3 |
protease, serine, 3 pseudogene 3 |
39333 |
0.17 |
chr12_3068801_3068977 | 3.09 |
TEAD4 |
TEA domain family member 4 |
73 |
0.96 |
chr11_73100197_73100477 | 3.09 |
RP11-809N8.2 |
|
7144 |
0.15 |
chr5_175956521_175957004 | 3.08 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr18_25757142_25757385 | 3.08 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
147 |
0.98 |
chr19_4014671_4014908 | 3.07 |
PIAS4 |
protein inhibitor of activated STAT, 4 |
7145 |
0.11 |
chr17_42386389_42386620 | 3.07 |
RUNDC3A |
RUN domain containing 3A |
540 |
0.42 |
chr16_3057668_3058079 | 3.07 |
LA16c-380H5.2 |
|
2771 |
0.09 |
chr8_143533078_143533273 | 3.06 |
BAI1 |
brain-specific angiogenesis inhibitor 1 |
2384 |
0.32 |
chr17_42298747_42298947 | 3.06 |
RP5-882C2.2 |
|
78 |
0.58 |
chr1_2431468_2431763 | 3.06 |
RP3-395M20.3 |
|
5697 |
0.11 |
chr17_76125547_76125737 | 3.06 |
TMC6 |
transmembrane channel-like 6 |
779 |
0.42 |
chr19_16254544_16254902 | 3.06 |
HSH2D |
hematopoietic SH2 domain containing |
177 |
0.92 |
chr3_10282522_10282828 | 3.06 |
TATDN2 |
TatD DNase domain containing 2 |
7032 |
0.13 |
chr10_52834025_52834306 | 3.05 |
PRKG1 |
protein kinase, cGMP-dependent, type I |
231 |
0.94 |
chr16_30484123_30484377 | 3.05 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
178 |
0.82 |
chr7_36610835_36611260 | 3.05 |
AOAH |
acyloxyacyl hydrolase (neutrophil) |
23215 |
0.18 |
chrX_153144566_153144767 | 3.05 |
LCA10 |
Putative lung carcinoma-associated protein 10 |
1461 |
0.22 |
chr19_39369157_39369690 | 3.04 |
RINL |
Ras and Rab interactor-like |
504 |
0.57 |
chrX_70839652_70840082 | 3.04 |
CXCR3 |
chemokine (C-X-C motif) receptor 3 |
1500 |
0.39 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 39.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
7.6 | 22.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
6.8 | 6.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
6.4 | 19.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
5.4 | 16.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
5.4 | 16.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
5.4 | 16.1 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
5.2 | 10.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
5.1 | 15.4 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
5.1 | 25.4 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
5.0 | 35.3 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
5.0 | 15.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
5.0 | 19.8 | GO:0000089 | mitotic metaphase(GO:0000089) |
4.9 | 14.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
4.8 | 28.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
4.8 | 4.8 | GO:0019724 | B cell mediated immunity(GO:0019724) |
4.8 | 38.1 | GO:0007172 | signal complex assembly(GO:0007172) |
4.8 | 14.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
4.7 | 4.7 | GO:0061054 | dermatome development(GO:0061054) |
4.7 | 23.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
4.6 | 18.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
4.5 | 9.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
4.4 | 13.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
4.4 | 4.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
4.2 | 12.7 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
4.2 | 12.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
4.2 | 4.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
4.1 | 12.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
4.1 | 16.2 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
4.0 | 12.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
4.0 | 12.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) auditory receptor cell fate determination(GO:0042668) inner ear receptor cell fate commitment(GO:0060120) |
4.0 | 12.0 | GO:0015809 | arginine transport(GO:0015809) |
4.0 | 12.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
3.9 | 7.9 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
3.9 | 15.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
3.9 | 3.9 | GO:0060242 | contact inhibition(GO:0060242) |
3.9 | 3.9 | GO:2000041 | planar cell polarity pathway involved in axis elongation(GO:0003402) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
3.9 | 11.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
3.9 | 3.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
3.8 | 11.5 | GO:0051451 | myoblast migration(GO:0051451) |
3.8 | 15.3 | GO:0010159 | specification of organ position(GO:0010159) |
3.8 | 11.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
3.8 | 37.7 | GO:0045061 | thymic T cell selection(GO:0045061) |
3.7 | 41.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
3.7 | 18.6 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
3.7 | 7.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
3.7 | 3.7 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
3.6 | 3.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
3.6 | 7.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
3.6 | 14.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
3.6 | 7.1 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
3.5 | 3.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
3.5 | 7.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
3.5 | 10.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.5 | 3.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
3.4 | 6.8 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
3.4 | 3.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
3.4 | 10.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
3.4 | 6.8 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
3.4 | 10.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
3.4 | 10.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.4 | 3.4 | GO:0050773 | regulation of dendrite development(GO:0050773) |
3.4 | 26.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
3.3 | 6.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
3.3 | 10.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
3.3 | 3.3 | GO:0002360 | T cell lineage commitment(GO:0002360) |
3.3 | 9.9 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
3.3 | 3.3 | GO:0090009 | primitive streak formation(GO:0090009) |
3.3 | 9.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
3.3 | 9.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
3.3 | 22.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.2 | 9.7 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
3.2 | 6.5 | GO:0042346 | regulation of NF-kappaB import into nucleus(GO:0042345) positive regulation of NF-kappaB import into nucleus(GO:0042346) NF-kappaB import into nucleus(GO:0042348) |
3.2 | 3.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
3.2 | 12.9 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
3.2 | 3.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
3.2 | 3.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.2 | 9.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
3.2 | 9.5 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
3.2 | 15.8 | GO:0070293 | renal absorption(GO:0070293) |
3.1 | 9.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
3.1 | 12.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
3.1 | 9.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
3.1 | 12.4 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
3.1 | 12.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.1 | 15.3 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
3.1 | 18.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
3.0 | 3.0 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
3.0 | 3.0 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
3.0 | 9.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
3.0 | 12.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
3.0 | 9.0 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
3.0 | 12.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
3.0 | 6.0 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
3.0 | 6.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
3.0 | 3.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
3.0 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.9 | 2.9 | GO:0048665 | neuron fate specification(GO:0048665) |
2.9 | 14.7 | GO:0048569 | post-embryonic organ development(GO:0048569) |
2.9 | 2.9 | GO:0007340 | acrosome reaction(GO:0007340) |
2.9 | 17.6 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
2.9 | 2.9 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
2.9 | 14.6 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
2.9 | 8.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
2.9 | 2.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.9 | 2.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
2.9 | 11.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.9 | 8.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.9 | 8.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
2.9 | 14.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
2.9 | 8.6 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
2.9 | 8.6 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
2.9 | 5.7 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
2.8 | 2.8 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
2.8 | 11.3 | GO:0018101 | protein citrullination(GO:0018101) |
2.8 | 5.6 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
2.8 | 8.4 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
2.8 | 8.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
2.8 | 2.8 | GO:0060560 | developmental growth involved in morphogenesis(GO:0060560) |
2.8 | 8.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
2.8 | 5.6 | GO:0060437 | lung growth(GO:0060437) |
2.8 | 25.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.8 | 8.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
2.8 | 38.7 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
2.8 | 11.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
2.8 | 30.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
2.7 | 13.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.7 | 8.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
2.7 | 2.7 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
2.7 | 5.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
2.7 | 10.9 | GO:0033197 | response to vitamin E(GO:0033197) |
2.7 | 19.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
2.7 | 8.1 | GO:0001821 | histamine secretion(GO:0001821) |
2.7 | 8.0 | GO:0003407 | neural retina development(GO:0003407) |
2.7 | 2.7 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
2.7 | 8.0 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
2.7 | 8.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
2.7 | 2.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
2.7 | 2.7 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
2.7 | 13.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
2.7 | 10.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
2.7 | 8.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
2.6 | 13.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
2.6 | 2.6 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
2.6 | 28.8 | GO:0031648 | protein destabilization(GO:0031648) |
2.6 | 5.2 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
2.6 | 47.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
2.6 | 5.2 | GO:0016358 | dendrite development(GO:0016358) |
2.6 | 5.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.6 | 10.4 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
2.6 | 2.6 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
2.6 | 7.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.6 | 10.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
2.6 | 2.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
2.6 | 7.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
2.6 | 7.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
2.5 | 7.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.5 | 7.6 | GO:0043276 | anoikis(GO:0043276) |
2.5 | 15.0 | GO:0050957 | equilibrioception(GO:0050957) |
2.5 | 12.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
2.5 | 2.5 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
2.5 | 19.9 | GO:0006491 | N-glycan processing(GO:0006491) |
2.5 | 2.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
2.5 | 12.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
2.5 | 12.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
2.5 | 4.9 | GO:0001705 | ectoderm formation(GO:0001705) |
2.4 | 2.4 | GO:1901861 | regulation of striated muscle tissue development(GO:0016202) regulation of muscle tissue development(GO:1901861) |
2.4 | 12.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.4 | 14.5 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
2.4 | 7.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
2.4 | 14.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.4 | 2.4 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
2.4 | 2.4 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
2.4 | 36.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
2.4 | 7.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.4 | 2.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
2.4 | 4.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
2.4 | 7.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.4 | 11.9 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
2.4 | 4.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
2.4 | 2.4 | GO:0002883 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
2.4 | 2.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
2.4 | 9.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.4 | 4.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
2.4 | 4.7 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
2.4 | 11.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.3 | 2.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
2.3 | 4.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
2.3 | 7.0 | GO:0002063 | chondrocyte development(GO:0002063) |
2.3 | 2.3 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
2.3 | 4.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.3 | 7.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
2.3 | 34.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
2.3 | 2.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
2.3 | 2.3 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
2.3 | 4.6 | GO:0071496 | cellular response to external stimulus(GO:0071496) |
2.3 | 6.9 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
2.3 | 9.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
2.3 | 6.9 | GO:0007416 | synapse assembly(GO:0007416) |
2.3 | 2.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
2.3 | 2.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
2.3 | 13.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
2.3 | 13.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
2.3 | 16.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
2.3 | 4.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.3 | 6.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.3 | 6.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.3 | 4.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
2.3 | 2.3 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
2.3 | 15.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
2.2 | 4.5 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
2.2 | 4.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
2.2 | 8.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
2.2 | 2.2 | GO:0009719 | response to endogenous stimulus(GO:0009719) |
2.2 | 6.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.2 | 6.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
2.2 | 11.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
2.2 | 4.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.2 | 2.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
2.2 | 6.6 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
2.2 | 8.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
2.2 | 8.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
2.2 | 2.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
2.2 | 2.2 | GO:0042634 | regulation of hair cycle(GO:0042634) |
2.2 | 11.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
2.2 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
2.2 | 4.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) negative regulation of action potential(GO:0045759) |
2.2 | 4.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
2.2 | 6.6 | GO:0002467 | germinal center formation(GO:0002467) |
2.2 | 8.7 | GO:0000154 | rRNA modification(GO:0000154) |
2.2 | 13.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
2.2 | 6.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
2.2 | 2.2 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
2.2 | 6.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.2 | 8.6 | GO:0001553 | luteinization(GO:0001553) |
2.2 | 38.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
2.2 | 2.2 | GO:0051318 | G1 phase(GO:0051318) |
2.1 | 4.3 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
2.1 | 4.3 | GO:0017085 | response to insecticide(GO:0017085) |
2.1 | 2.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
2.1 | 2.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
2.1 | 8.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
2.1 | 10.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
2.1 | 55.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
2.1 | 6.4 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
2.1 | 8.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
2.1 | 2.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.1 | 6.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.1 | 6.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
2.1 | 2.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
2.1 | 6.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
2.1 | 2.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
2.1 | 6.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.1 | 4.2 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
2.1 | 6.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.1 | 6.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
2.1 | 52.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
2.1 | 18.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
2.1 | 24.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
2.1 | 6.2 | GO:0045058 | T cell selection(GO:0045058) |
2.1 | 4.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
2.1 | 8.2 | GO:0001820 | serotonin secretion(GO:0001820) |
2.1 | 2.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
2.1 | 4.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
2.1 | 4.1 | GO:0098900 | regulation of action potential(GO:0098900) |
2.1 | 6.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
2.1 | 10.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
2.0 | 10.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
2.0 | 2.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
2.0 | 6.1 | GO:0016322 | neuron remodeling(GO:0016322) |
2.0 | 6.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.0 | 10.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
2.0 | 4.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.0 | 2.0 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
2.0 | 20.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
2.0 | 2.0 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
2.0 | 14.3 | GO:0034311 | diol metabolic process(GO:0034311) |
2.0 | 6.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
2.0 | 2.0 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
2.0 | 2.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
2.0 | 4.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
2.0 | 4.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
2.0 | 4.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
2.0 | 8.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
2.0 | 2.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
2.0 | 10.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
2.0 | 18.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
2.0 | 10.0 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
2.0 | 6.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
2.0 | 11.9 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
2.0 | 9.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
2.0 | 2.0 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
2.0 | 13.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
2.0 | 7.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
2.0 | 2.0 | GO:0051668 | localization within membrane(GO:0051668) |
2.0 | 7.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
2.0 | 2.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.0 | 2.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.0 | 7.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
2.0 | 13.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
2.0 | 17.6 | GO:0001706 | endoderm formation(GO:0001706) |
2.0 | 25.4 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
2.0 | 2.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
1.9 | 11.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.9 | 5.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
1.9 | 29.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
1.9 | 1.9 | GO:0072179 | nephric duct formation(GO:0072179) |
1.9 | 1.9 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
1.9 | 15.5 | GO:0000303 | response to superoxide(GO:0000303) |
1.9 | 5.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.9 | 5.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.9 | 25.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.9 | 15.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
1.9 | 3.9 | GO:0042100 | B cell proliferation(GO:0042100) |
1.9 | 9.6 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
1.9 | 5.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.9 | 3.8 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
1.9 | 9.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.9 | 3.8 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
1.9 | 9.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.9 | 3.8 | GO:0002689 | negative regulation of leukocyte migration(GO:0002686) negative regulation of leukocyte chemotaxis(GO:0002689) |
1.9 | 40.3 | GO:0043487 | regulation of RNA stability(GO:0043487) regulation of mRNA stability(GO:0043488) |
1.9 | 1.9 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.9 | 7.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.9 | 13.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.9 | 19.1 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
1.9 | 3.8 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
1.9 | 3.8 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
1.9 | 7.6 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
1.9 | 3.8 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
1.9 | 3.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.9 | 13.3 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
1.9 | 7.6 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
1.9 | 7.6 | GO:0046618 | drug export(GO:0046618) |
1.9 | 1.9 | GO:0071503 | response to heparin(GO:0071503) |
1.9 | 5.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.9 | 5.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.9 | 5.6 | GO:0006565 | L-serine catabolic process(GO:0006565) |
1.9 | 11.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.9 | 5.6 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
1.9 | 5.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.9 | 1.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.9 | 9.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.9 | 7.4 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
1.9 | 1.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.9 | 1.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.9 | 5.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
1.8 | 5.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.8 | 5.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.8 | 3.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.8 | 7.3 | GO:0032202 | telomere assembly(GO:0032202) |
1.8 | 5.5 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
1.8 | 3.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.8 | 10.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
1.8 | 1.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.8 | 7.3 | GO:0030878 | thyroid gland development(GO:0030878) |
1.8 | 5.4 | GO:0050860 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.8 | 1.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
1.8 | 7.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
1.8 | 1.8 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
1.8 | 1.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.8 | 5.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
1.8 | 3.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.8 | 5.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.8 | 3.6 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
1.8 | 5.4 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
1.8 | 9.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.8 | 5.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.8 | 12.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
1.8 | 5.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.8 | 21.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
1.8 | 1.8 | GO:0032609 | interferon-gamma production(GO:0032609) |
1.8 | 5.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.8 | 7.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
1.8 | 5.3 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
1.8 | 3.5 | GO:0072079 | nephron tubule formation(GO:0072079) |
1.8 | 14.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.8 | 10.6 | GO:0031000 | response to caffeine(GO:0031000) |
1.8 | 1.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.8 | 10.6 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
1.8 | 47.3 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
1.8 | 5.3 | GO:0031529 | ruffle organization(GO:0031529) |
1.8 | 14.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.8 | 1.8 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
1.7 | 5.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
1.7 | 12.2 | GO:0006983 | ER overload response(GO:0006983) |
1.7 | 22.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.7 | 5.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.7 | 6.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
1.7 | 12.1 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
1.7 | 15.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
1.7 | 6.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.7 | 1.7 | GO:0021761 | limbic system development(GO:0021761) |
1.7 | 3.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.7 | 1.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.7 | 3.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
1.7 | 15.3 | GO:0016925 | protein sumoylation(GO:0016925) |
1.7 | 76.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
1.7 | 18.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
1.7 | 8.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.7 | 5.1 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
1.7 | 1.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.7 | 6.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.7 | 5.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.7 | 15.1 | GO:0010039 | response to iron ion(GO:0010039) |
1.7 | 5.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
1.7 | 1.7 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
1.7 | 13.4 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
1.7 | 1.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.7 | 5.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.7 | 1.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.7 | 3.3 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
1.7 | 25.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
1.7 | 10.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.7 | 5.0 | GO:0032310 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) prostaglandin secretion(GO:0032310) |
1.7 | 6.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
1.7 | 1.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
1.7 | 6.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.7 | 13.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
1.7 | 5.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.7 | 1.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.7 | 6.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.7 | 6.6 | GO:0008218 | bioluminescence(GO:0008218) |
1.7 | 66.2 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.6 | 3.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.6 | 8.2 | GO:0071295 | cellular response to vitamin(GO:0071295) |
1.6 | 1.6 | GO:0060296 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.6 | 1.6 | GO:0019042 | viral latency(GO:0019042) |
1.6 | 9.8 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.6 | 6.5 | GO:0002418 | immune response to tumor cell(GO:0002418) |
1.6 | 1.6 | GO:0010458 | exit from mitosis(GO:0010458) |
1.6 | 4.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
1.6 | 1.6 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
1.6 | 1.6 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
1.6 | 9.7 | GO:0045116 | protein neddylation(GO:0045116) |
1.6 | 9.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.6 | 3.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
1.6 | 1.6 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
1.6 | 9.7 | GO:0051322 | anaphase(GO:0051322) |
1.6 | 20.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.6 | 6.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
1.6 | 8.0 | GO:0002456 | T cell mediated immunity(GO:0002456) |
1.6 | 19.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
1.6 | 1.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) positive regulation of histone H3-K4 methylation(GO:0051571) |
1.6 | 9.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.6 | 6.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.6 | 1.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.6 | 6.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.6 | 3.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.6 | 11.0 | GO:0045576 | mast cell activation(GO:0045576) |
1.6 | 1.6 | GO:0006304 | DNA modification(GO:0006304) |
1.6 | 6.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.6 | 3.1 | GO:0090399 | replicative senescence(GO:0090399) |
1.6 | 12.5 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
1.6 | 6.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.6 | 4.7 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
1.6 | 10.9 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
1.6 | 14.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.6 | 4.7 | GO:0006477 | protein sulfation(GO:0006477) |
1.5 | 3.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.5 | 4.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.5 | 12.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.5 | 3.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.5 | 4.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.5 | 1.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.5 | 4.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.5 | 1.5 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.5 | 7.7 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
1.5 | 10.7 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
1.5 | 3.1 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
1.5 | 1.5 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
1.5 | 15.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.5 | 6.1 | GO:0051299 | centrosome separation(GO:0051299) |
1.5 | 1.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.5 | 4.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.5 | 4.6 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
1.5 | 3.0 | GO:0009648 | photoperiodism(GO:0009648) |
1.5 | 1.5 | GO:0048103 | somatic stem cell division(GO:0048103) |
1.5 | 10.6 | GO:0045730 | respiratory burst(GO:0045730) |
1.5 | 1.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.5 | 1.5 | GO:0060326 | cell chemotaxis(GO:0060326) |
1.5 | 13.6 | GO:0032456 | endocytic recycling(GO:0032456) |
1.5 | 10.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.5 | 10.5 | GO:0034332 | adherens junction organization(GO:0034332) |
1.5 | 1.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.5 | 7.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.5 | 1.5 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
1.5 | 3.0 | GO:1903409 | reactive oxygen species biosynthetic process(GO:1903409) |
1.5 | 6.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.5 | 3.0 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
1.5 | 22.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.5 | 11.9 | GO:0048536 | spleen development(GO:0048536) |
1.5 | 7.4 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
1.5 | 10.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
1.5 | 1.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
1.5 | 2.9 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.5 | 2.9 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.5 | 22.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
1.5 | 5.9 | GO:0006415 | translational termination(GO:0006415) |
1.5 | 1.5 | GO:0048515 | spermatid differentiation(GO:0048515) |
1.5 | 11.7 | GO:0007379 | segment specification(GO:0007379) |
1.5 | 1.5 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
1.5 | 30.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.5 | 4.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.5 | 1.5 | GO:0018343 | protein farnesylation(GO:0018343) |
1.5 | 4.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.5 | 10.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.5 | 4.4 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
1.5 | 4.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.5 | 23.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
1.5 | 62.4 | GO:0007498 | mesoderm development(GO:0007498) |
1.4 | 5.8 | GO:0008354 | germ cell migration(GO:0008354) |
1.4 | 1.4 | GO:0070141 | response to UV-A(GO:0070141) |
1.4 | 1.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.4 | 1.4 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
1.4 | 1.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.4 | 2.9 | GO:0002507 | tolerance induction(GO:0002507) |
1.4 | 7.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
1.4 | 10.0 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
1.4 | 9.9 | GO:0006839 | mitochondrial transport(GO:0006839) |
1.4 | 5.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
1.4 | 5.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
1.4 | 1.4 | GO:0031670 | cellular response to nutrient(GO:0031670) |
1.4 | 1.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.4 | 18.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
1.4 | 21.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.4 | 2.8 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
1.4 | 2.8 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.4 | 1.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.4 | 2.8 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
1.4 | 7.0 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
1.4 | 5.6 | GO:0051452 | intracellular pH reduction(GO:0051452) |
1.4 | 2.8 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.4 | 1.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.4 | 4.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.4 | 2.8 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
1.4 | 2.8 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.4 | 6.9 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
1.4 | 36.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.4 | 52.7 | GO:0006968 | cellular defense response(GO:0006968) |
1.4 | 1.4 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
1.4 | 5.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.4 | 2.8 | GO:0010761 | fibroblast migration(GO:0010761) |
1.4 | 5.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.4 | 8.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
1.4 | 6.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.4 | 4.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.4 | 4.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.4 | 2.7 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
1.4 | 4.1 | GO:0001945 | lymph vessel development(GO:0001945) |
1.4 | 8.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.4 | 10.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.4 | 98.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
1.4 | 2.7 | GO:0060402 | calcium ion transport into cytosol(GO:0060402) |
1.4 | 13.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
1.4 | 9.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.4 | 5.4 | GO:0008347 | glial cell migration(GO:0008347) |
1.4 | 4.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
1.4 | 1.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.4 | 2.7 | GO:0002118 | aggressive behavior(GO:0002118) male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
1.4 | 4.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.3 | 1.3 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.3 | 4.0 | GO:0009215 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
1.3 | 6.7 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
1.3 | 2.7 | GO:0032060 | bleb assembly(GO:0032060) |
1.3 | 4.0 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
1.3 | 2.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.3 | 1.3 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) |
1.3 | 1.3 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.3 | 5.3 | GO:0032368 | regulation of lipid transport(GO:0032368) |
1.3 | 33.3 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
1.3 | 4.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
1.3 | 2.7 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
1.3 | 1.3 | GO:0021543 | pallium development(GO:0021543) |
1.3 | 5.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.3 | 1.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
1.3 | 7.9 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
1.3 | 4.0 | GO:0042640 | anagen(GO:0042640) |
1.3 | 17.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.3 | 1.3 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
1.3 | 6.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.3 | 9.2 | GO:0031647 | regulation of protein stability(GO:0031647) |
1.3 | 31.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.3 | 1.3 | GO:0019532 | oxalate transport(GO:0019532) |
1.3 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
1.3 | 1.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.3 | 6.5 | GO:0030163 | protein catabolic process(GO:0030163) |
1.3 | 2.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
1.3 | 3.9 | GO:0007143 | female meiotic division(GO:0007143) |
1.3 | 5.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.3 | 1.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
1.3 | 1.3 | GO:0006903 | vesicle targeting(GO:0006903) |
1.3 | 1.3 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
1.3 | 1.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
1.3 | 2.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
1.3 | 1.3 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
1.3 | 1.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
1.3 | 16.7 | GO:0009309 | amine biosynthetic process(GO:0009309) |
1.3 | 38.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
1.3 | 1.3 | GO:1902224 | ketone body metabolic process(GO:1902224) |
1.3 | 17.9 | GO:0007032 | endosome organization(GO:0007032) |
1.3 | 1.3 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
1.3 | 3.8 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
1.3 | 43.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.3 | 2.6 | GO:0048520 | positive regulation of behavior(GO:0048520) |
1.3 | 12.8 | GO:1901800 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
1.3 | 8.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.3 | 2.5 | GO:0007144 | female meiosis I(GO:0007144) |
1.3 | 7.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.3 | 6.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
1.3 | 1.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.3 | 11.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.3 | 1.3 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
1.3 | 1.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.3 | 2.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
1.3 | 6.3 | GO:0030903 | notochord development(GO:0030903) |
1.3 | 3.8 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
1.3 | 3.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.3 | 6.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.3 | 6.3 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
1.2 | 7.5 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
1.2 | 6.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.2 | 2.5 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
1.2 | 2.5 | GO:0071103 | DNA conformation change(GO:0071103) |
1.2 | 3.7 | GO:0051546 | keratinocyte migration(GO:0051546) |
1.2 | 31.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
1.2 | 30.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
1.2 | 2.5 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
1.2 | 13.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.2 | 45.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
1.2 | 64.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
1.2 | 2.5 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
1.2 | 6.1 | GO:0030323 | respiratory tube development(GO:0030323) |
1.2 | 1.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.2 | 1.2 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
1.2 | 3.7 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.2 | 1.2 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
1.2 | 1.2 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
1.2 | 4.9 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
1.2 | 6.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.2 | 3.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.2 | 4.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.2 | 1.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.2 | 2.4 | GO:0014904 | myotube cell development(GO:0014904) |
1.2 | 2.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
1.2 | 8.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
1.2 | 14.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
1.2 | 3.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.2 | 1.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.2 | 3.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.2 | 8.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.2 | 20.5 | GO:0019079 | viral genome replication(GO:0019079) |
1.2 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.2 | 9.6 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
1.2 | 80.6 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
1.2 | 4.8 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
1.2 | 26.4 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
1.2 | 3.6 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
1.2 | 4.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
1.2 | 3.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.2 | 3.6 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.2 | 1.2 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
1.2 | 6.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
1.2 | 3.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.2 | 5.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.2 | 5.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.2 | 1.2 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
1.2 | 1.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
1.2 | 2.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.2 | 1.2 | GO:0021754 | facial nucleus development(GO:0021754) |
1.2 | 5.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
1.2 | 9.4 | GO:0008380 | RNA splicing(GO:0008380) |
1.2 | 3.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
1.2 | 16.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
1.2 | 17.6 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
1.2 | 7.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.2 | 7.0 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
1.2 | 2.3 | GO:0033198 | response to ATP(GO:0033198) |
1.2 | 1.2 | GO:0007613 | memory(GO:0007613) |
1.2 | 4.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
1.2 | 7.0 | GO:0010043 | response to zinc ion(GO:0010043) |
1.2 | 119.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
1.2 | 2.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
1.2 | 2.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
1.2 | 2.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
1.2 | 1.2 | GO:0051301 | cell division(GO:0051301) |
1.2 | 3.5 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
1.2 | 2.3 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
1.1 | 2.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.1 | 4.6 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
1.1 | 5.7 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
1.1 | 4.6 | GO:0006342 | chromatin silencing(GO:0006342) |
1.1 | 2.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.1 | 1.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
1.1 | 5.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.1 | 16.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.1 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.1 | 1.1 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
1.1 | 2.3 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
1.1 | 4.6 | GO:0031100 | organ regeneration(GO:0031100) |
1.1 | 18.2 | GO:0034968 | histone lysine methylation(GO:0034968) |
1.1 | 2.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.1 | 6.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.1 | 4.5 | GO:0010955 | negative regulation of humoral immune response(GO:0002921) negative regulation of protein processing(GO:0010955) negative regulation of complement activation(GO:0045916) negative regulation of protein maturation(GO:1903318) negative regulation of protein activation cascade(GO:2000258) |
1.1 | 4.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.1 | 3.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.1 | 5.6 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
1.1 | 2.2 | GO:0042523 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
1.1 | 2.2 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
1.1 | 2.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.1 | 1.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
1.1 | 2.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
1.1 | 19.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.1 | 7.8 | GO:0001825 | blastocyst formation(GO:0001825) |
1.1 | 1.1 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
1.1 | 5.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.1 | 3.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.1 | 15.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.1 | 4.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.1 | 8.9 | GO:0001709 | cell fate determination(GO:0001709) |
1.1 | 17.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
1.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 43.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
1.1 | 1.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.1 | 2.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.1 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.1 | 7.7 | GO:0046348 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
1.1 | 2.2 | GO:0001881 | receptor recycling(GO:0001881) |
1.1 | 9.9 | GO:0010469 | regulation of receptor activity(GO:0010469) |
1.1 | 13.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
1.1 | 2.2 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
1.1 | 2.2 | GO:0016577 | histone demethylation(GO:0016577) |
1.1 | 3.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
1.1 | 5.5 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
1.1 | 5.5 | GO:0014888 | striated muscle adaptation(GO:0014888) |
1.1 | 1.1 | GO:0009268 | response to pH(GO:0009268) |
1.1 | 13.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.1 | 2.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
1.1 | 2.2 | GO:0015074 | DNA integration(GO:0015074) |
1.1 | 3.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.1 | 2.2 | GO:0008306 | associative learning(GO:0008306) |
1.1 | 3.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.1 | 1.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.1 | 171.9 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
1.1 | 15.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
1.1 | 7.6 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 5.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.1 | 1.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.1 | 1.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
1.1 | 14.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.1 | 2.2 | GO:0070265 | necrotic cell death(GO:0070265) |
1.1 | 2.2 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
1.1 | 7.5 | GO:0007141 | male meiosis I(GO:0007141) |
1.1 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.1 | 1.1 | GO:0001302 | replicative cell aging(GO:0001302) |
1.1 | 18.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
1.1 | 3.2 | GO:0016559 | peroxisome fission(GO:0016559) |
1.1 | 1.1 | GO:0045619 | regulation of lymphocyte differentiation(GO:0045619) |
1.1 | 1.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
1.1 | 6.4 | GO:0046777 | protein autophosphorylation(GO:0046777) |
1.1 | 3.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.1 | 1.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.1 | 1.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
1.1 | 5.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.1 | 3.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.1 | 1.1 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
1.1 | 1.1 | GO:0014070 | response to organic cyclic compound(GO:0014070) |
1.1 | 6.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
1.1 | 13.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
1.0 | 8.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
1.0 | 7.3 | GO:0051324 | prophase(GO:0051324) |
1.0 | 3.1 | GO:0001906 | cell killing(GO:0001906) |
1.0 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.0 | 172.6 | GO:0016568 | chromatin modification(GO:0016568) |
1.0 | 4.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.0 | 5.2 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
1.0 | 5.2 | GO:0060606 | tube closure(GO:0060606) |
1.0 | 2.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
1.0 | 3.1 | GO:0045056 | transcytosis(GO:0045056) |
1.0 | 2.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
1.0 | 1.0 | GO:0032623 | interleukin-2 production(GO:0032623) |
1.0 | 2.1 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
1.0 | 2.1 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
1.0 | 2.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
1.0 | 1.0 | GO:0060157 | urinary bladder development(GO:0060157) |
1.0 | 54.6 | GO:0050900 | leukocyte migration(GO:0050900) |
1.0 | 5.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
1.0 | 5.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
1.0 | 2.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 2.0 | GO:0042129 | regulation of T cell proliferation(GO:0042129) |
1.0 | 1.0 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
1.0 | 2.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 4.1 | GO:0045006 | DNA deamination(GO:0045006) |
1.0 | 1.0 | GO:0046931 | pore complex assembly(GO:0046931) |
1.0 | 8.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
1.0 | 39.6 | GO:0006914 | autophagy(GO:0006914) |
1.0 | 1.0 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
1.0 | 5.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
1.0 | 3.0 | GO:0001892 | embryonic placenta development(GO:0001892) |
1.0 | 2.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.0 | 11.1 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
1.0 | 1.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
1.0 | 2.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
1.0 | 5.0 | GO:0006546 | glycine catabolic process(GO:0006546) |
1.0 | 5.0 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
1.0 | 3.0 | GO:0009301 | snRNA transcription(GO:0009301) |
1.0 | 7.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.0 | 2.0 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
1.0 | 14.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
1.0 | 9.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
1.0 | 1.0 | GO:0060033 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
1.0 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.0 | 4.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.0 | 1.0 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
1.0 | 34.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
1.0 | 2.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.0 | 3.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.0 | 17.9 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
1.0 | 32.7 | GO:0098602 | single organism cell adhesion(GO:0098602) |
1.0 | 6.9 | GO:0051923 | sulfation(GO:0051923) |
1.0 | 1.0 | GO:0042940 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) D-amino acid transport(GO:0042940) amino acid import(GO:0043090) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 3.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
1.0 | 8.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
1.0 | 8.9 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
1.0 | 3.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.0 | 2.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.0 | 6.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.0 | 2.0 | GO:0021915 | neural tube development(GO:0021915) |
1.0 | 2.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
1.0 | 1.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.0 | 2.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
1.0 | 2.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.0 | 6.8 | GO:0009127 | purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
1.0 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
1.0 | 3.9 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
1.0 | 2.9 | GO:0045007 | depurination(GO:0045007) |
1.0 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.0 | 1.0 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
1.0 | 6.8 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
1.0 | 1.0 | GO:0001649 | osteoblast differentiation(GO:0001649) |
1.0 | 1.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
1.0 | 1.9 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
1.0 | 1.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.0 | 1.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
1.0 | 4.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.0 | 5.8 | GO:0030902 | hindbrain development(GO:0030902) |
1.0 | 2.9 | GO:0010288 | response to lead ion(GO:0010288) |
1.0 | 3.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
1.0 | 1.0 | GO:0072177 | mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) |
1.0 | 1.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
1.0 | 5.8 | GO:0051302 | regulation of cell division(GO:0051302) |
1.0 | 20.2 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
1.0 | 10.6 | GO:0006414 | translational elongation(GO:0006414) |
1.0 | 2.9 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
1.0 | 2.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
1.0 | 29.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
1.0 | 1.9 | GO:0006874 | cellular calcium ion homeostasis(GO:0006874) |
1.0 | 9.6 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
1.0 | 13.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
1.0 | 1.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
1.0 | 1.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
1.0 | 1.9 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.0 | 1.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
1.0 | 3.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.9 | 19.0 | GO:0044782 | cilium organization(GO:0044782) |
0.9 | 19.9 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.9 | 4.7 | GO:0007140 | male meiosis(GO:0007140) |
0.9 | 12.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.9 | 0.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.9 | 95.8 | GO:0030168 | platelet activation(GO:0030168) |
0.9 | 1.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.9 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.9 | 5.6 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.9 | 2.8 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.9 | 26.1 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
0.9 | 2.8 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.9 | 1.9 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.9 | 1.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.9 | 0.9 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.9 | 0.9 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.9 | 0.9 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.9 | 69.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.9 | 3.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.9 | 13.8 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.9 | 12.0 | GO:0035036 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.9 | 1.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 6.5 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.9 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.9 | 1.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.9 | 3.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 9.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.9 | 3.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.9 | 1.8 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.9 | 4.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.9 | 1.8 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.9 | 0.9 | GO:0015992 | proton transport(GO:0015992) |
0.9 | 1.8 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.9 | 84.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.9 | 0.9 | GO:0006818 | hydrogen transport(GO:0006818) |
0.9 | 11.0 | GO:0048489 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.9 | 1.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.9 | 4.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.9 | 15.4 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.9 | 20.8 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.9 | 28.1 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.9 | 0.9 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.9 | 0.9 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.9 | 0.9 | GO:0031016 | pancreas development(GO:0031016) |
0.9 | 8.1 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.9 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.9 | 0.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.9 | 5.4 | GO:0051169 | nuclear transport(GO:0051169) |
0.9 | 4.5 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.9 | 5.4 | GO:0019835 | cytolysis(GO:0019835) |
0.9 | 2.7 | GO:0007530 | sex determination(GO:0007530) |
0.9 | 1.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 6.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.9 | 21.4 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.9 | 16.1 | GO:0000084 | mitotic S phase(GO:0000084) |
0.9 | 69.5 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.9 | 2.7 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.9 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
0.9 | 0.9 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.9 | 2.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.9 | 2.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.9 | 0.9 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.9 | 0.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.9 | 3.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.9 | 1.8 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.9 | 7.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.9 | 4.4 | GO:0002209 | behavioral defense response(GO:0002209) |
0.9 | 8.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.9 | 5.3 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
0.9 | 10.6 | GO:0046942 | organic acid transport(GO:0015849) carboxylic acid transport(GO:0046942) |
0.9 | 2.6 | GO:0051193 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) regulation of ATP metabolic process(GO:1903578) |
0.9 | 3.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.9 | 7.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.9 | 5.3 | GO:0050890 | cognition(GO:0050890) |
0.9 | 1.7 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.9 | 0.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.9 | 1.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.9 | 0.9 | GO:0001832 | blastocyst growth(GO:0001832) |
0.9 | 1.7 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.9 | 0.9 | GO:0030031 | cell projection assembly(GO:0030031) |
0.9 | 0.9 | GO:0046620 | regulation of organ growth(GO:0046620) |
0.9 | 6.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.9 | 21.7 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.9 | 4.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.9 | 1.7 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.9 | 6.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.9 | 3.5 | GO:0007512 | adult heart development(GO:0007512) |
0.9 | 9.5 | GO:0051402 | neuron apoptotic process(GO:0051402) |
0.9 | 0.9 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.9 | 2.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.9 | 0.9 | GO:0006560 | proline metabolic process(GO:0006560) |
0.9 | 20.7 | GO:0071772 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.9 | 10.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.9 | 4.3 | GO:0042044 | fluid transport(GO:0042044) |
0.9 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.9 | 4.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.9 | 7.7 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.9 | 2.6 | GO:0009409 | response to cold(GO:0009409) |
0.9 | 5.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.9 | 0.9 | GO:0006266 | DNA ligation(GO:0006266) V(D)J recombination(GO:0033151) |
0.9 | 3.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.8 | 5.9 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.8 | 0.8 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.8 | 1.7 | GO:0022011 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.8 | 3.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.8 | 0.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.8 | 0.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.8 | 1.7 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.8 | 8.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.8 | 0.8 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.8 | 64.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.8 | 4.2 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.8 | 8.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.8 | 5.9 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.8 | 11.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.8 | 8.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.8 | 0.8 | GO:1904062 | regulation of cation transmembrane transport(GO:1904062) |
0.8 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 2.5 | GO:0070727 | cellular macromolecule localization(GO:0070727) |
0.8 | 1.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.8 | 15.0 | GO:0051607 | defense response to virus(GO:0051607) |
0.8 | 0.8 | GO:0051954 | positive regulation of amine transport(GO:0051954) |
0.8 | 2.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.8 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.8 | 4.1 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.8 | 1.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 1.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.8 | 6.6 | GO:0006862 | nucleotide transport(GO:0006862) |
0.8 | 15.6 | GO:0006413 | translational initiation(GO:0006413) |
0.8 | 26.3 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.8 | 0.8 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.8 | 1.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.8 | 2.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.8 | 0.8 | GO:0032094 | response to food(GO:0032094) |
0.8 | 8.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.8 | 4.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.8 | 8.1 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
0.8 | 193.5 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.8 | 4.0 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.8 | 3.2 | GO:0021675 | nerve development(GO:0021675) |
0.8 | 1.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.8 | 0.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 0.8 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.8 | 6.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.8 | 0.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.8 | 6.4 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.8 | 4.8 | GO:0016049 | cell growth(GO:0016049) |
0.8 | 7.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.8 | 3.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.8 | 4.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.8 | 15.2 | GO:0006302 | double-strand break repair(GO:0006302) |
0.8 | 2.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 83.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 12.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.8 | 2.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.8 | 2.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.8 | 7.1 | GO:0051899 | membrane depolarization(GO:0051899) |
0.8 | 3.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 2.4 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.8 | 17.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 7.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.8 | 1.6 | GO:0031929 | TOR signaling(GO:0031929) |
0.8 | 0.8 | GO:0032652 | regulation of interleukin-1 production(GO:0032652) |
0.8 | 5.5 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.8 | 4.7 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.8 | 0.8 | GO:0031349 | positive regulation of defense response(GO:0031349) |
0.8 | 49.8 | GO:0034248 | regulation of cellular amide metabolic process(GO:0034248) |
0.8 | 5.4 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.8 | 10.8 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.8 | 2.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.8 | 8.5 | GO:0007041 | lysosomal transport(GO:0007041) |
0.8 | 2.3 | GO:0051053 | negative regulation of DNA replication(GO:0008156) negative regulation of DNA metabolic process(GO:0051053) |
0.8 | 2.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 24.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.8 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.8 | 13.0 | GO:0007286 | spermatid development(GO:0007286) |
0.8 | 39.1 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.8 | 6.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.8 | 2.3 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.8 | 1.5 | GO:0031669 | cellular response to nutrient levels(GO:0031669) |
0.8 | 8.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.8 | 3.0 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.8 | 17.5 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.8 | 1.5 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.8 | 3.0 | GO:0042493 | response to drug(GO:0042493) |
0.8 | 56.1 | GO:0006325 | chromatin organization(GO:0006325) |
0.8 | 2.3 | GO:0007507 | heart development(GO:0007507) |
0.8 | 1.5 | GO:0060438 | trachea development(GO:0060438) |
0.8 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.8 | 3.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.8 | 4.5 | GO:0009791 | post-embryonic development(GO:0009791) |
0.8 | 3.8 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.8 | 3.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 0.7 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.7 | 23.9 | GO:0000279 | M phase(GO:0000279) |
0.7 | 3.7 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.7 | 0.7 | GO:0060456 | regulation of saliva secretion(GO:0046877) positive regulation of digestive system process(GO:0060456) |
0.7 | 64.1 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.7 | 5.2 | GO:0016311 | dephosphorylation(GO:0016311) |
0.7 | 2.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.7 | 1.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.7 | 1.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 1.5 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.7 | 1.5 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.7 | 17.7 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.7 | 2.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.7 | 4.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.7 | 1.5 | GO:0061053 | somite development(GO:0061053) |
0.7 | 1.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.7 | 9.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.7 | 8.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.7 | 2.2 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.7 | 5.1 | GO:0007389 | pattern specification process(GO:0007389) |
0.7 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.7 | 38.5 | GO:0006457 | protein folding(GO:0006457) |
0.7 | 3.6 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.7 | 63.1 | GO:0006397 | mRNA processing(GO:0006397) |
0.7 | 4.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.7 | 23.9 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.7 | 23.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.7 | 1.4 | GO:0042026 | protein refolding(GO:0042026) |
0.7 | 0.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.7 | 1.4 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.7 | 4.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.7 | 3.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.7 | 0.7 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.7 | 2.1 | GO:1905144 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 2.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.7 | 5.0 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.7 | 7.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.7 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.7 | 1.4 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.7 | 652.2 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.7 | 1.4 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.7 | 7.0 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.7 | 6.3 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.7 | 0.7 | GO:0051181 | cofactor transport(GO:0051181) |
0.7 | 2.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 83.8 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.7 | 2.7 | GO:0010467 | gene expression(GO:0010467) |
0.7 | 4.8 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.7 | 20.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.7 | 0.7 | GO:0032328 | alanine transport(GO:0032328) |
0.7 | 2.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 10.2 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.7 | 3.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.7 | 0.7 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.7 | 21.0 | GO:0006260 | DNA replication(GO:0006260) |
0.7 | 1.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.7 | 1.3 | GO:0051494 | negative regulation of cytoskeleton organization(GO:0051494) |
0.7 | 3.4 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.7 | 4.7 | GO:0048477 | oogenesis(GO:0048477) |
0.7 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.7 | 10.0 | GO:0000910 | cytokinesis(GO:0000910) |
0.7 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.7 | 40.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.7 | 9.3 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.7 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 11.3 | GO:0009968 | negative regulation of signal transduction(GO:0009968) |
0.7 | 12.6 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.7 | 1.3 | GO:0051783 | regulation of nuclear division(GO:0051783) |
0.7 | 8.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.7 | 5.3 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.7 | 5.3 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.7 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.7 | 4.6 | GO:0009615 | response to virus(GO:0009615) |
0.7 | 103.4 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.7 | 2.6 | GO:0007281 | germ cell development(GO:0007281) |
0.7 | 3.3 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.7 | 2.0 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.7 | 22.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.7 | 2.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.6 | 21.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.6 | 1.3 | GO:0048535 | lymph node development(GO:0048535) |
0.6 | 4.5 | GO:0009607 | response to biotic stimulus(GO:0009607) |
0.6 | 164.0 | GO:0008219 | cell death(GO:0008219) |
0.6 | 25.8 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.6 | 121.3 | GO:0002376 | immune system process(GO:0002376) |
0.6 | 1.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.6 | 3.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.6 | 0.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.6 | 7.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.6 | 1.3 | GO:0048511 | rhythmic process(GO:0048511) |
0.6 | 1.9 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.6 | 0.6 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.6 | 0.6 | GO:0042310 | vasoconstriction(GO:0042310) |
0.6 | 216.9 | GO:0015031 | protein transport(GO:0015031) |
0.6 | 11.3 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.6 | 23.5 | GO:0008283 | cell proliferation(GO:0008283) |
0.6 | 9.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.6 | 2.5 | GO:0031638 | zymogen activation(GO:0031638) |
0.6 | 3.7 | GO:0007623 | circadian rhythm(GO:0007623) |
0.6 | 50.9 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) |
0.6 | 2.4 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
0.6 | 12.8 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.6 | 3.0 | GO:0018193 | peptidyl-amino acid modification(GO:0018193) |
0.6 | 1.8 | GO:0051338 | regulation of transferase activity(GO:0051338) |
0.6 | 1.2 | GO:0090150 | establishment of protein localization to membrane(GO:0090150) |
0.6 | 0.6 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.6 | 4.2 | GO:0007586 | digestion(GO:0007586) |
0.6 | 7.2 | GO:0051321 | meiotic cell cycle(GO:0051321) meiotic cell cycle process(GO:1903046) |
0.6 | 25.7 | GO:0006869 | lipid transport(GO:0006869) |
0.6 | 5.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.6 | 2.4 | GO:0030282 | bone mineralization(GO:0030282) |
0.6 | 1.2 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.6 | 1.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) cytochrome complex assembly(GO:0017004) |
0.6 | 31.8 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.6 | 8.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.6 | 22.3 | GO:0040008 | regulation of growth(GO:0040008) |
0.6 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 0.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.6 | 2.3 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) ERBB signaling pathway(GO:0038127) |
0.6 | 1.1 | GO:0061025 | membrane fusion(GO:0061025) |
0.6 | 10.7 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.6 | 25.1 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.6 | 31.3 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.6 | 1.1 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
0.6 | 1.1 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.5 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 0.5 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.5 | 2.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.5 | 1.6 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.5 | 2.2 | GO:0015893 | drug transport(GO:0015893) |
0.5 | 1.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.5 | 12.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.5 | 2.7 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.5 | 67.6 | GO:0016310 | phosphorylation(GO:0016310) |
0.5 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 16.0 | GO:0042330 | chemotaxis(GO:0006935) taxis(GO:0042330) |
0.5 | 6.4 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.5 | 0.5 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.5 | 0.5 | GO:0019098 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.5 | 1.6 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.5 | 5.2 | GO:0009566 | fertilization(GO:0009566) |
0.5 | 3.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.5 | 0.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.5 | 1.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.5 | 1.0 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.5 | 5.1 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.5 | 1.0 | GO:0045596 | negative regulation of cell differentiation(GO:0045596) |
0.5 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.5 | 1.0 | GO:0009101 | glycoprotein biosynthetic process(GO:0009101) |
0.5 | 1.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.5 | 1.0 | GO:0048638 | regulation of developmental growth(GO:0048638) |
0.5 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.5 | 2.5 | GO:0048514 | blood vessel morphogenesis(GO:0048514) |
0.5 | 1.0 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.5 | 1.0 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.5 | 26.8 | GO:0050953 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.5 | 1.0 | GO:0007034 | vacuolar transport(GO:0007034) |
0.5 | 2.9 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
0.5 | 1.4 | GO:0009743 | response to carbohydrate(GO:0009743) |
0.5 | 185.7 | GO:0007165 | signal transduction(GO:0007165) |
0.5 | 0.9 | GO:0043102 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.5 | 5.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.5 | 1.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.5 | 129.1 | GO:0006508 | proteolysis(GO:0006508) |
0.5 | 3.6 | GO:0009790 | embryo development(GO:0009790) |
0.5 | 1.4 | GO:0015695 | organic cation transport(GO:0015695) |
0.5 | 4.1 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.4 | 3.6 | GO:0009628 | response to abiotic stimulus(GO:0009628) |
0.4 | 1.8 | GO:0007059 | chromosome segregation(GO:0007059) |
0.4 | 2.2 | GO:0015669 | gas transport(GO:0015669) |
0.4 | 25.7 | GO:0036211 | cellular protein modification process(GO:0006464) protein modification process(GO:0036211) |
0.4 | 42.2 | GO:0007267 | cell-cell signaling(GO:0007267) |
0.4 | 2.4 | GO:1901698 | response to nitrogen compound(GO:1901698) |
0.4 | 1.2 | GO:0009069 | serine family amino acid metabolic process(GO:0009069) |
0.4 | 1.2 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.4 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 2.7 | GO:0015711 | organic anion transport(GO:0015711) |
0.4 | 1.9 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.4 | 0.8 | GO:0061024 | membrane organization(GO:0061024) |
0.4 | 1.1 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.4 | 8.3 | GO:0007154 | cell communication(GO:0007154) |
0.4 | 0.8 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.4 | 1.9 | GO:0032259 | methylation(GO:0032259) |
0.4 | 0.8 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.4 | 0.4 | GO:0051262 | protein tetramerization(GO:0051262) |
0.4 | 4.9 | GO:0050878 | regulation of body fluid levels(GO:0050878) |
0.4 | 14.2 | GO:0007049 | cell cycle(GO:0007049) |
0.4 | 1.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.4 | 3.9 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.4 | 3.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.3 | 2.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 1.0 | GO:0044267 | cellular protein metabolic process(GO:0044267) |
0.3 | 1.0 | GO:0070206 | protein trimerization(GO:0070206) |
0.3 | 1.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.3 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
0.3 | 120.4 | GO:0006810 | transport(GO:0006810) |
0.3 | 0.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 1.3 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.3 | 0.6 | GO:0043473 | pigmentation(GO:0043473) |
0.3 | 5.4 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.3 | 1.6 | GO:0009059 | macromolecule biosynthetic process(GO:0009059) |
0.3 | 0.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 0.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.3 | 4.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 40.9 | GO:0007155 | cell adhesion(GO:0007155) |
0.3 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 48.5 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.3 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 2.7 | GO:0034330 | cell junction organization(GO:0034330) |
0.3 | 0.8 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.3 | 0.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 1.0 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.3 | 12.4 | GO:0006952 | defense response(GO:0006952) |
0.3 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.3 | 1.5 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.2 | 4.7 | GO:0007517 | muscle organ development(GO:0007517) |
0.2 | 12.8 | GO:0007276 | gamete generation(GO:0007276) |
0.2 | 19.1 | GO:0006629 | lipid metabolic process(GO:0006629) |
0.2 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.5 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.2 | 1.5 | GO:0016477 | cell migration(GO:0016477) |
0.2 | 0.2 | GO:0007626 | locomotory behavior(GO:0007626) |
0.2 | 5.6 | GO:0006950 | response to stress(GO:0006950) |
0.2 | 0.2 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.2 | 0.9 | GO:0009887 | organ morphogenesis(GO:0009887) |
0.2 | 2.5 | GO:0022008 | neurogenesis(GO:0022008) |
0.2 | 0.5 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.2 | GO:0051241 | negative regulation of multicellular organismal process(GO:0051241) |
0.2 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:0009605 | response to external stimulus(GO:0009605) |
0.1 | 0.1 | GO:0009308 | amine metabolic process(GO:0009308) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.5 | GO:0040007 | growth(GO:0040007) |
0.1 | 0.1 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 11.9 | GO:0008152 | metabolic process(GO:0008152) |
0.1 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 20.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 19.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
4.7 | 14.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
4.6 | 4.6 | GO:0005921 | gap junction(GO:0005921) |
4.0 | 35.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
3.8 | 11.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.5 | 10.6 | GO:0044462 | external encapsulating structure part(GO:0044462) |
3.4 | 13.7 | GO:0043218 | compact myelin(GO:0043218) |
3.3 | 10.0 | GO:0072487 | MSL complex(GO:0072487) |
3.3 | 9.9 | GO:0032009 | early phagosome(GO:0032009) |
3.2 | 9.6 | GO:0070820 | tertiary granule(GO:0070820) |
3.1 | 18.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
3.0 | 6.0 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
3.0 | 14.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.0 | 3.0 | GO:0031090 | organelle membrane(GO:0031090) |
2.9 | 41.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
2.9 | 14.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.8 | 13.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.6 | 15.8 | GO:0005883 | neurofilament(GO:0005883) |
2.6 | 18.3 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
2.6 | 26.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
2.6 | 20.4 | GO:0001891 | phagocytic cup(GO:0001891) |
2.6 | 51.1 | GO:0031519 | PcG protein complex(GO:0031519) |
2.5 | 22.8 | GO:0043209 | myelin sheath(GO:0043209) |
2.5 | 17.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
2.5 | 15.1 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
2.5 | 10.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.5 | 7.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
2.5 | 7.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
2.4 | 50.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
2.4 | 9.6 | GO:0030914 | STAGA complex(GO:0030914) |
2.4 | 7.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.4 | 9.6 | GO:0005827 | polar microtubule(GO:0005827) |
2.4 | 7.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.4 | 7.1 | GO:0031904 | endosome lumen(GO:0031904) |
2.3 | 18.4 | GO:0005861 | troponin complex(GO:0005861) |
2.3 | 6.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.2 | 22.2 | GO:0001772 | immunological synapse(GO:0001772) |
2.2 | 11.0 | GO:0000791 | euchromatin(GO:0000791) |
2.2 | 4.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.2 | 13.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.2 | 2.2 | GO:0005839 | proteasome core complex(GO:0005839) |
2.2 | 10.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.2 | 4.3 | GO:0031931 | TORC1 complex(GO:0031931) |
2.2 | 15.1 | GO:0034451 | centriolar satellite(GO:0034451) |
2.1 | 14.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
2.1 | 31.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
2.1 | 6.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.1 | 6.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
2.0 | 8.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
2.0 | 8.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
2.0 | 6.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
2.0 | 18.2 | GO:0032991 | macromolecular complex(GO:0032991) |
2.0 | 10.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
2.0 | 22.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
2.0 | 2.0 | GO:0070938 | contractile ring(GO:0070938) |
2.0 | 16.0 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
2.0 | 23.7 | GO:0031528 | microvillus membrane(GO:0031528) |
2.0 | 41.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.9 | 17.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.9 | 15.4 | GO:0030313 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
1.9 | 5.8 | GO:0071986 | Ragulator complex(GO:0071986) |
1.9 | 15.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
1.9 | 9.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.8 | 1.8 | GO:0042827 | platelet dense granule(GO:0042827) |
1.8 | 3.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.8 | 5.5 | GO:0030008 | TRAPP complex(GO:0030008) |
1.8 | 35.6 | GO:0005776 | autophagosome(GO:0005776) |
1.8 | 10.7 | GO:0005915 | zonula adherens(GO:0005915) |
1.8 | 10.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.8 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.7 | 12.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.7 | 8.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.7 | 29.5 | GO:0005844 | polysome(GO:0005844) |
1.7 | 27.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
1.7 | 8.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.7 | 6.8 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
1.7 | 5.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.7 | 1.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
1.7 | 8.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.7 | 58.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.7 | 13.3 | GO:0005694 | chromosome(GO:0005694) |
1.7 | 5.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.7 | 6.6 | GO:0070552 | BRISC complex(GO:0070552) |
1.6 | 90.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.6 | 4.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.6 | 71.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.6 | 6.5 | GO:0016589 | NURF complex(GO:0016589) |
1.6 | 35.7 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
1.6 | 11.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.6 | 9.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.6 | 18.9 | GO:0042588 | zymogen granule(GO:0042588) |
1.6 | 15.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.6 | 15.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.6 | 3.1 | GO:0032059 | bleb(GO:0032059) |
1.5 | 3.1 | GO:0071565 | nBAF complex(GO:0071565) |
1.5 | 4.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.5 | 20.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.5 | 110.9 | GO:0030027 | lamellipodium(GO:0030027) |
1.5 | 3.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.5 | 3.1 | GO:0038201 | TOR complex(GO:0038201) |
1.5 | 12.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
1.5 | 7.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 4.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.5 | 3.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.5 | 12.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
1.5 | 11.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.5 | 1.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.5 | 113.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.5 | 44.0 | GO:0031252 | cell leading edge(GO:0031252) |
1.5 | 13.2 | GO:0030057 | desmosome(GO:0030057) |
1.5 | 5.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.5 | 1.5 | GO:0044437 | vacuolar part(GO:0044437) |
1.4 | 5.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.4 | 4.3 | GO:0030315 | T-tubule(GO:0030315) |
1.4 | 8.6 | GO:0042382 | paraspeckles(GO:0042382) |
1.4 | 2.8 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
1.4 | 160.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.4 | 28.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.4 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.4 | 9.8 | GO:0051233 | spindle midzone(GO:0051233) |
1.4 | 11.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.4 | 5.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.4 | 1.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.4 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
1.4 | 27.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.4 | 5.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.4 | 9.5 | GO:0098533 | ATP-binding cassette (ABC) transporter complex(GO:0043190) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
1.4 | 20.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.4 | 12.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
1.4 | 35.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.4 | 5.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.4 | 4.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
1.3 | 10.8 | GO:0030118 | clathrin coat(GO:0030118) |
1.3 | 25.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.3 | 4.0 | GO:0071437 | invadopodium(GO:0071437) |
1.3 | 49.2 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
1.3 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.3 | 1.3 | GO:0016234 | inclusion body(GO:0016234) |
1.3 | 9.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.3 | 11.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.3 | 3.9 | GO:0032590 | dendrite membrane(GO:0032590) |
1.3 | 10.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.3 | 34.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
1.3 | 2.6 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
1.3 | 3.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.3 | 79.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
1.3 | 6.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.3 | 39.6 | GO:0016592 | mediator complex(GO:0016592) |
1.3 | 3.8 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
1.3 | 19.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.3 | 115.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.3 | 29.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.3 | 6.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.3 | 3.8 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.2 | 86.7 | GO:0019717 | obsolete synaptosome(GO:0019717) |
1.2 | 6.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.2 | 2.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 11.0 | GO:0042555 | MCM complex(GO:0042555) |
1.2 | 2.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.2 | 25.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.2 | 23.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.2 | 6.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.2 | 3.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.2 | 8.4 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 3.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.2 | 7.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.2 | 7.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.2 | 1.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.2 | 2.4 | GO:0031012 | extracellular matrix(GO:0031012) |
1.2 | 4.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.2 | 7.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
1.2 | 8.2 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
1.2 | 23.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.2 | 2.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.2 | 5.8 | GO:0045179 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
1.2 | 21.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.2 | 17.3 | GO:0032420 | stereocilium(GO:0032420) |
1.1 | 73.5 | GO:0005643 | nuclear pore(GO:0005643) |
1.1 | 2.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.1 | 2.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
1.1 | 13.6 | GO:0005796 | Golgi lumen(GO:0005796) |
1.1 | 21.6 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
1.1 | 18.2 | GO:0030496 | midbody(GO:0030496) |
1.1 | 25.0 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
1.1 | 4.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
1.1 | 5.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.1 | 26.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.1 | 22.3 | GO:0032587 | ruffle membrane(GO:0032587) |
1.1 | 13.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.1 | 4.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.1 | 35.4 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
1.1 | 13.2 | GO:0030175 | filopodium(GO:0030175) |
1.1 | 46.2 | GO:0016605 | PML body(GO:0016605) |
1.1 | 24.2 | GO:0005657 | replication fork(GO:0005657) |
1.1 | 53.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.1 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 6.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.1 | 32.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
1.1 | 217.9 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 6.5 | GO:0070652 | HAUS complex(GO:0070652) |
1.1 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.1 | 15.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.1 | 4.3 | GO:0046930 | pore complex(GO:0046930) |
1.1 | 6.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.1 | 28.0 | GO:0031902 | late endosome membrane(GO:0031902) |
1.1 | 3.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.1 | 7.5 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
1.1 | 10.7 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
1.1 | 97.0 | GO:0005769 | early endosome(GO:0005769) |
1.1 | 2.1 | GO:0042599 | lamellar body(GO:0042599) |
1.1 | 18.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.1 | 80.2 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
1.1 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 67.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
1.0 | 91.9 | GO:0016607 | nuclear speck(GO:0016607) |
1.0 | 31.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
1.0 | 4.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
1.0 | 1.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.0 | 3.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.0 | 1.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.0 | 9.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.0 | 17.5 | GO:0042641 | actomyosin(GO:0042641) |
1.0 | 5.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.0 | 3.1 | GO:0034464 | BBSome(GO:0034464) |
1.0 | 50.2 | GO:0030424 | axon(GO:0030424) |
1.0 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.0 | 93.8 | GO:0005635 | nuclear envelope(GO:0005635) |
1.0 | 1.0 | GO:0000800 | lateral element(GO:0000800) |
1.0 | 144.5 | GO:0005794 | Golgi apparatus(GO:0005794) |
1.0 | 21.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.0 | 9.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
1.0 | 2.0 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
1.0 | 40.5 | GO:0000922 | spindle pole(GO:0000922) |
1.0 | 11.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
1.0 | 3.0 | GO:0043034 | costamere(GO:0043034) |
1.0 | 1355.1 | GO:0005829 | cytosol(GO:0005829) |
1.0 | 93.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.0 | 278.8 | GO:0000139 | Golgi membrane(GO:0000139) |
1.0 | 6.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.0 | 1.0 | GO:0005683 | U7 snRNP(GO:0005683) |
1.0 | 16.7 | GO:0000502 | proteasome complex(GO:0000502) |
1.0 | 2.0 | GO:0031430 | M band(GO:0031430) |
1.0 | 7.8 | GO:0005770 | late endosome(GO:0005770) |
1.0 | 4.9 | GO:0000796 | condensin complex(GO:0000796) |
1.0 | 50.7 | GO:0005768 | endosome(GO:0005768) |
1.0 | 7.7 | GO:0005811 | lipid particle(GO:0005811) |
1.0 | 19.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.0 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.0 | 39.1 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
1.0 | 77.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.0 | 18.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.9 | 1.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.9 | 3095.3 | GO:0005634 | nucleus(GO:0005634) |
0.9 | 3.7 | GO:0000145 | exocyst(GO:0000145) |
0.9 | 3.6 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.9 | 623.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.9 | 1.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.9 | 7.1 | GO:0005840 | ribosome(GO:0005840) |
0.9 | 207.5 | GO:0005886 | plasma membrane(GO:0005886) |
0.9 | 6.8 | GO:0005819 | spindle(GO:0005819) |
0.8 | 0.8 | GO:0009925 | basal plasma membrane(GO:0009925) basal part of cell(GO:0045178) |
0.8 | 9.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 37.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.8 | 5.8 | GO:0030018 | Z disc(GO:0030018) |
0.8 | 78.7 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.8 | 38.2 | GO:0030141 | secretory granule(GO:0030141) |
0.8 | 223.7 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.8 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.8 | 349.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.8 | 0.8 | GO:0097458 | neuron part(GO:0097458) |
0.8 | 3.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.8 | 26.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.8 | 235.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.8 | 8.4 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.7 | 1.5 | GO:0009986 | cell surface(GO:0009986) |
0.7 | 42.6 | GO:0031982 | vesicle(GO:0031982) |
0.7 | 25.4 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.7 | 28.9 | GO:0031974 | membrane-enclosed lumen(GO:0031974) |
0.7 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 1497.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.7 | 1.4 | GO:0044297 | cell body(GO:0044297) |
0.7 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 43.8 | GO:0005874 | microtubule(GO:0005874) |
0.7 | 22.8 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.6 | 26.7 | GO:0016020 | membrane(GO:0016020) |
0.6 | 3.1 | GO:0005792 | obsolete microsome(GO:0005792) |
0.6 | 462.1 | GO:0005737 | cytoplasm(GO:0005737) |
0.5 | 1.6 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.5 | 0.5 | GO:0072372 | primary cilium(GO:0072372) |
0.5 | 202.2 | GO:0005622 | intracellular(GO:0005622) |
0.5 | 1.0 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.4 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 3.4 | GO:0005929 | cilium(GO:0005929) |
0.2 | 195.8 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 19.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
5.7 | 22.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
5.4 | 16.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
5.2 | 15.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
4.9 | 9.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
4.8 | 19.3 | GO:0031014 | troponin T binding(GO:0031014) |
4.8 | 14.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
4.8 | 28.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
4.3 | 12.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
4.2 | 12.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
4.1 | 12.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
4.0 | 16.0 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
3.9 | 11.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
3.9 | 23.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
3.8 | 11.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
3.8 | 3.8 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
3.8 | 15.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
3.7 | 14.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.7 | 29.3 | GO:0050700 | CARD domain binding(GO:0050700) |
3.6 | 10.9 | GO:0050693 | LBD domain binding(GO:0050693) |
3.6 | 10.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
3.6 | 10.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.6 | 10.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.6 | 14.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.5 | 21.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
3.5 | 10.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.4 | 16.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
3.4 | 10.1 | GO:0005113 | patched binding(GO:0005113) |
3.3 | 30.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
3.3 | 19.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
3.3 | 13.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
3.3 | 9.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.2 | 6.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
3.2 | 25.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
3.2 | 12.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
3.2 | 9.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.1 | 37.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
3.1 | 15.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
3.1 | 12.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
3.1 | 9.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.1 | 3.1 | GO:0005035 | death receptor activity(GO:0005035) |
3.1 | 12.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.0 | 6.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.0 | 18.1 | GO:0016208 | AMP binding(GO:0016208) |
3.0 | 51.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
3.0 | 8.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
2.9 | 8.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.9 | 14.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
2.9 | 14.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
2.9 | 5.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.9 | 5.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.9 | 17.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.9 | 11.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.9 | 34.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
2.9 | 2.9 | GO:0033691 | sialic acid binding(GO:0033691) |
2.8 | 14.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.8 | 11.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.8 | 19.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.8 | 8.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
2.8 | 8.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.8 | 2.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.7 | 8.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.7 | 16.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.7 | 16.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.7 | 8.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
2.7 | 8.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.7 | 10.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
2.7 | 98.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
2.7 | 8.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.6 | 29.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.6 | 21.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
2.6 | 7.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
2.6 | 13.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
2.6 | 7.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.6 | 23.7 | GO:0030276 | clathrin binding(GO:0030276) |
2.6 | 23.7 | GO:0005112 | Notch binding(GO:0005112) |
2.6 | 18.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.6 | 10.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
2.6 | 7.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.6 | 10.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.6 | 25.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.6 | 15.5 | GO:0051400 | BH domain binding(GO:0051400) |
2.6 | 10.3 | GO:0045569 | TRAIL binding(GO:0045569) |
2.6 | 41.2 | GO:0043621 | protein self-association(GO:0043621) |
2.6 | 12.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.6 | 12.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.6 | 7.7 | GO:0043398 | HLH domain binding(GO:0043398) |
2.6 | 25.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.5 | 7.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
2.5 | 17.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
2.5 | 12.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.5 | 5.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
2.5 | 7.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.5 | 12.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.5 | 2.5 | GO:0003896 | DNA primase activity(GO:0003896) |
2.5 | 9.9 | GO:0030911 | TPR domain binding(GO:0030911) |
2.5 | 4.9 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
2.5 | 4.9 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
2.5 | 14.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.4 | 7.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
2.4 | 9.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
2.4 | 4.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
2.4 | 12.0 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
2.4 | 9.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
2.4 | 7.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.4 | 12.0 | GO:0004904 | interferon receptor activity(GO:0004904) |
2.4 | 12.0 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
2.4 | 4.8 | GO:0031491 | nucleosome binding(GO:0031491) |
2.4 | 16.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
2.4 | 2.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
2.3 | 42.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
2.3 | 18.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.3 | 16.3 | GO:0005522 | profilin binding(GO:0005522) |
2.3 | 39.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.3 | 9.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.3 | 6.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.3 | 43.4 | GO:0050699 | WW domain binding(GO:0050699) |
2.3 | 6.8 | GO:0019863 | IgE binding(GO:0019863) |
2.3 | 97.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.3 | 9.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.3 | 6.8 | GO:0035197 | siRNA binding(GO:0035197) |
2.2 | 6.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.2 | 4.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.2 | 6.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.2 | 15.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.2 | 11.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.2 | 30.9 | GO:0070888 | E-box binding(GO:0070888) |
2.2 | 11.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.2 | 2.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
2.2 | 10.9 | GO:0070402 | NADPH binding(GO:0070402) |
2.2 | 15.3 | GO:0003785 | actin monomer binding(GO:0003785) |
2.2 | 2.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
2.2 | 8.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.1 | 8.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
2.1 | 6.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.1 | 6.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.1 | 19.2 | GO:0030553 | cGMP binding(GO:0030553) |
2.1 | 4.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
2.1 | 6.4 | GO:0030172 | troponin C binding(GO:0030172) |
2.1 | 12.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
2.1 | 6.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.1 | 6.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.1 | 14.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
2.1 | 8.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.1 | 4.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
2.1 | 8.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
2.1 | 10.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.1 | 16.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
2.1 | 10.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
2.1 | 6.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.1 | 6.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.0 | 6.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
2.0 | 20.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
2.0 | 2.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.0 | 34.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.0 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
2.0 | 10.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.0 | 68.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
2.0 | 12.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.0 | 8.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.0 | 12.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
2.0 | 8.0 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
2.0 | 8.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.0 | 12.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
2.0 | 10.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.0 | 2.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
2.0 | 6.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.0 | 15.8 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
2.0 | 5.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.0 | 23.5 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
2.0 | 7.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
2.0 | 11.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.9 | 15.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.9 | 9.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.9 | 5.8 | GO:0034452 | dynactin binding(GO:0034452) |
1.9 | 5.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.9 | 5.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.9 | 5.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.9 | 5.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.9 | 40.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.9 | 3.8 | GO:0032451 | demethylase activity(GO:0032451) |
1.9 | 1.9 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
1.9 | 5.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
1.9 | 5.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.9 | 11.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
1.9 | 26.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
1.9 | 7.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 11.2 | GO:0005521 | lamin binding(GO:0005521) |
1.9 | 7.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.9 | 5.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.9 | 18.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.8 | 3.7 | GO:0031013 | troponin I binding(GO:0031013) |
1.8 | 11.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
1.8 | 3.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.8 | 3.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.8 | 12.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.8 | 63.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.8 | 19.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.8 | 7.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.8 | 18.0 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
1.8 | 19.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.8 | 1.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.8 | 5.4 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.8 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.8 | 3.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.8 | 5.3 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
1.8 | 5.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.8 | 133.3 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
1.8 | 7.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
1.8 | 7.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.8 | 12.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.7 | 5.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.7 | 7.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.7 | 13.9 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.7 | 8.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.7 | 5.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.7 | 6.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.7 | 3.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 6.8 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.7 | 5.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
1.7 | 3.4 | GO:0051425 | PTB domain binding(GO:0051425) |
1.7 | 10.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
1.7 | 13.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.7 | 6.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.7 | 10.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.7 | 10.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.7 | 36.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
1.7 | 8.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.7 | 1.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.7 | 11.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.6 | 4.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.6 | 8.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.6 | 4.9 | GO:0003680 | AT DNA binding(GO:0003680) |
1.6 | 54.0 | GO:0001948 | glycoprotein binding(GO:0001948) |
1.6 | 4.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.6 | 3.3 | GO:0016799 | uracil DNA N-glycosylase activity(GO:0004844) hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) DNA N-glycosylase activity(GO:0019104) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.6 | 3.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
1.6 | 14.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.6 | 8.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
1.6 | 24.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.6 | 3.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.6 | 12.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.6 | 14.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.6 | 6.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.6 | 348.8 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
1.6 | 7.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.6 | 4.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.6 | 1.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.6 | 3.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.6 | 1.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.6 | 6.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
1.6 | 7.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.6 | 9.3 | GO:0031432 | titin binding(GO:0031432) |
1.6 | 4.7 | GO:0010843 | obsolete promoter binding(GO:0010843) |
1.6 | 7.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.5 | 4.6 | GO:0004875 | complement receptor activity(GO:0004875) |
1.5 | 3.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.5 | 10.8 | GO:0000339 | RNA cap binding(GO:0000339) |
1.5 | 4.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.5 | 7.7 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
1.5 | 4.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
1.5 | 1.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.5 | 10.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.5 | 19.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.5 | 6.1 | GO:0015925 | galactosidase activity(GO:0015925) |
1.5 | 4.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.5 | 4.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.5 | 3.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.5 | 1.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.5 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.5 | 19.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.5 | 7.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
1.5 | 7.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.5 | 7.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.5 | 5.9 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.5 | 5.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.5 | 8.8 | GO:0030274 | LIM domain binding(GO:0030274) |
1.5 | 38.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.5 | 5.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.5 | 8.8 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
1.5 | 131.2 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
1.5 | 5.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.5 | 13.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.5 | 7.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.4 | 4.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.4 | 4.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.4 | 2.9 | GO:0046790 | virion binding(GO:0046790) |
1.4 | 1.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.4 | 4.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.4 | 4.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.4 | 4.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.4 | 9.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.4 | 4.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.4 | 4.2 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
1.4 | 2.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.4 | 5.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.4 | 7.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.4 | 4.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.4 | 15.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.4 | 65.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
1.4 | 11.1 | GO:0019864 | IgG binding(GO:0019864) |
1.4 | 19.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.4 | 4.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.4 | 4.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
1.4 | 5.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.4 | 6.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
1.4 | 5.4 | GO:0004340 | glucokinase activity(GO:0004340) |
1.4 | 8.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.4 | 5.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.3 | 4.0 | GO:0019956 | chemokine binding(GO:0019956) |
1.3 | 4.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.3 | 1.3 | GO:0008061 | chitin binding(GO:0008061) |
1.3 | 9.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.3 | 14.8 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
1.3 | 30.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.3 | 4.0 | GO:0030371 | translation repressor activity(GO:0030371) |
1.3 | 18.7 | GO:0019209 | kinase activator activity(GO:0019209) |
1.3 | 6.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.3 | 10.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.3 | 33.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
1.3 | 4.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
1.3 | 6.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.3 | 17.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
1.3 | 9.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.3 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.3 | 9.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 17.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.3 | 96.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
1.3 | 11.7 | GO:0045296 | cadherin binding(GO:0045296) |
1.3 | 19.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.3 | 2.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.3 | 5.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.3 | 15.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.3 | 9.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.3 | 15.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.3 | 11.6 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
1.3 | 5.1 | GO:0001848 | complement binding(GO:0001848) |
1.3 | 2.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.3 | 3.8 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
1.3 | 6.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.3 | 30.5 | GO:0019843 | rRNA binding(GO:0019843) |
1.3 | 15.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.3 | 13.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.3 | 5.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
1.3 | 11.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.3 | 3.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.3 | 34.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.3 | 1.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
1.3 | 3.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.3 | 3.8 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
1.3 | 11.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.2 | 18.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 22.4 | GO:0035586 | purinergic receptor activity(GO:0035586) |
1.2 | 6.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
1.2 | 1.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.2 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.2 | 8.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.2 | 24.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.2 | 18.3 | GO:0051117 | ATPase binding(GO:0051117) |
1.2 | 6.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.2 | 9.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.2 | 3.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.2 | 3.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
1.2 | 4.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 3.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 7.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.2 | 4.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.2 | 25.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
1.2 | 300.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
1.2 | 19.4 | GO:0035064 | methylated histone binding(GO:0035064) |
1.2 | 18.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
1.2 | 6.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.2 | 7.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.2 | 15.7 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
1.2 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.2 | 2.4 | GO:0042806 | fucose binding(GO:0042806) |
1.2 | 137.8 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
1.2 | 4.8 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
1.2 | 9.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.2 | 1.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.2 | 2.4 | GO:0005534 | galactose binding(GO:0005534) |
1.2 | 9.5 | GO:0030515 | snoRNA binding(GO:0030515) |
1.2 | 13.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.2 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.2 | 3.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.2 | 1.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
1.2 | 5.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.2 | 3.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
1.2 | 4.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.2 | 5.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.2 | 18.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
1.2 | 24.4 | GO:0003823 | antigen binding(GO:0003823) |
1.2 | 10.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
1.2 | 7.0 | GO:0050733 | RS domain binding(GO:0050733) |
1.2 | 32.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.2 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.2 | 24.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.2 | 3.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.1 | 26.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.1 | 10.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 1.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
1.1 | 5.7 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
1.1 | 5.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 8.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
1.1 | 4.5 | GO:0004064 | arylesterase activity(GO:0004064) |
1.1 | 5.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.1 | 20.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.1 | 1.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
1.1 | 12.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.1 | 3.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.1 | 2.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.1 | 5.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.1 | 5.6 | GO:0015923 | mannosidase activity(GO:0015923) |
1.1 | 6.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.1 | 4.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.1 | 6.7 | GO:0070403 | NAD+ binding(GO:0070403) |
1.1 | 14.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 1.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
1.1 | 7.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.1 | 6.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.1 | 10.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.1 | 85.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
1.1 | 3.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.1 | 7.7 | GO:0004568 | chitinase activity(GO:0004568) |
1.1 | 1.1 | GO:0016151 | nickel cation binding(GO:0016151) |
1.1 | 3.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.1 | 3.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.1 | 6.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.1 | 3.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.1 | 5.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.1 | 4.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.1 | 2.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.1 | 7.7 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
1.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.1 | 2.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
1.1 | 4.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
1.1 | 300.6 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
1.1 | 29.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
1.1 | 6.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.1 | 1.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
1.1 | 3.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.1 | 3.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.1 | 12.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.1 | 4.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.1 | 2.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.1 | 1.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
1.1 | 5.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 2.1 | GO:0035173 | histone kinase activity(GO:0035173) |
1.1 | 5.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
1.0 | 6.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.0 | 17.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.0 | 6.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.0 | 8.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.0 | 2.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.0 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.0 | 12.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.0 | 3.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.0 | 21.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.0 | 3.1 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
1.0 | 2.1 | GO:0005048 | signal sequence binding(GO:0005048) |
1.0 | 4.1 | GO:0035240 | dopamine binding(GO:0035240) |
1.0 | 3.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.0 | 5.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.0 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 19.5 | GO:0019003 | GDP binding(GO:0019003) |
1.0 | 3.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.0 | 9.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.0 | 88.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
1.0 | 15.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.0 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 3.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 2.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 45.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 45.7 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
1.0 | 3.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.0 | 3.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.0 | 4.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
1.0 | 17.0 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
1.0 | 22.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 3.0 | GO:0070513 | death domain binding(GO:0070513) |
1.0 | 1.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.0 | 2.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.0 | 7.0 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
1.0 | 1.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.0 | 2.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 13.8 | GO:0008483 | transaminase activity(GO:0008483) |
1.0 | 3.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.0 | 3.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
1.0 | 4.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
1.0 | 2.9 | GO:0043531 | ADP binding(GO:0043531) |
1.0 | 8.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.0 | 6.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
1.0 | 9.7 | GO:0043130 | ubiquitin-like protein binding(GO:0032182) ubiquitin binding(GO:0043130) |
1.0 | 4.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
1.0 | 1.9 | GO:0043121 | neurotrophin binding(GO:0043121) |
1.0 | 1.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.0 | 4.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.0 | 1.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.0 | 5.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.0 | 11.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.0 | 7.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.0 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 5.7 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
1.0 | 4.8 | GO:0015288 | porin activity(GO:0015288) |
1.0 | 36.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.0 | 6.7 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.9 | 37.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.9 | 3.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.9 | 4.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.9 | 12.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.9 | 3.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.9 | 8.4 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.9 | 8.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 0.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.9 | 2.8 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.9 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.9 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.9 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.9 | 0.9 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.9 | 0.9 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.9 | 1.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.9 | 1.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.9 | 8.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.9 | 6.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 0.9 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.9 | 2.7 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.9 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.9 | 0.9 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.9 | 0.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.9 | 10.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.9 | 21.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.9 | 6.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.9 | 4.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.9 | 258.5 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.9 | 8.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.9 | 0.9 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.9 | 0.9 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.9 | 27.1 | GO:0008134 | transcription factor binding(GO:0008134) |
0.9 | 9.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.9 | 1.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.9 | 5.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.9 | 24.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.9 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.9 | 1065.4 | GO:0003677 | DNA binding(GO:0003677) |
0.9 | 7.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.9 | 32.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.9 | 2.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.9 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 4.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.9 | 26.7 | GO:0004871 | signal transducer activity(GO:0004871) |
0.9 | 6.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 5.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.9 | 15.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.9 | 2.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.9 | 8.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.9 | 2.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.9 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.9 | 4.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.9 | 26.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.9 | 6.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.9 | 4.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.9 | 2.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 21.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.9 | 8.6 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.9 | 31.6 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.9 | 4.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 135.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.9 | 2.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.9 | 6.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.9 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 1.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.8 | 27.1 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.8 | 28.7 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.8 | 2.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 8.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 10.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.8 | 2.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 8.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 17.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.8 | 3.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.8 | 34.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.8 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.8 | 12.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.8 | 10.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.8 | 10.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.8 | 6.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.8 | 3.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.8 | 20.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.8 | 3.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 2.4 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.8 | 28.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.8 | 1.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.8 | 5.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.8 | 22.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.8 | 9.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.8 | 3.2 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.8 | 17.4 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.8 | 0.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.8 | 2.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 12.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.8 | 7.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 4.7 | GO:0043176 | amine binding(GO:0043176) |
0.8 | 17.3 | GO:0015297 | antiporter activity(GO:0015297) |
0.8 | 7.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.8 | 2.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.8 | 10.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.8 | 5.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.8 | 1.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.8 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.8 | 3.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.8 | 1.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.8 | 3.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 4.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.8 | 23.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.8 | 13.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.8 | 19.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.8 | 11.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 540.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.7 | 1.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.7 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 4.4 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.7 | 1.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.7 | 14.0 | GO:0016829 | lyase activity(GO:0016829) |
0.7 | 35.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.7 | 5.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.7 | 3.7 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 5.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 3.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.7 | 1.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 2.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.7 | 4.4 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.7 | 230.1 | GO:0003723 | RNA binding(GO:0003723) |
0.7 | 42.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.7 | 2.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.7 | 6.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.7 | 21.7 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.7 | 0.7 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.7 | 3.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 2.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.7 | 2.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.7 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 2.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.7 | 5.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.7 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 2.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.7 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 14.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.7 | 0.7 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.7 | 4.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 2.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 2.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.7 | 7.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.7 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 6.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.7 | 0.7 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.7 | 4.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.7 | 12.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.7 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 2.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.7 | 2.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.7 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.7 | 2.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.7 | 4.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 3.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.7 | 1.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 1.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.7 | 51.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.6 | 82.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 2.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.6 | 9.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 3.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.6 | 93.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.6 | 1.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.6 | 3.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.6 | 10.7 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.6 | 5.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.6 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 34.9 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
0.6 | 2.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 14.2 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.6 | 1.9 | GO:0015926 | glucosidase activity(GO:0015926) |
0.6 | 1.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.6 | 19.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.6 | 1.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.6 | 6.1 | GO:0051287 | NAD binding(GO:0051287) |
0.6 | 112.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.6 | 126.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.6 | 7.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.6 | 1.8 | GO:0016744 | transketolase activity(GO:0004802) transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 3.0 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 3.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.6 | 1.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.6 | 1.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 1.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 0.6 | GO:0016877 | ligase activity, forming carbon-sulfur bonds(GO:0016877) |
0.6 | 4.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.6 | 4.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 5.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.6 | 1341.6 | GO:0005515 | protein binding(GO:0005515) |
0.6 | 4.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.6 | 2.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.6 | 5.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 30.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.6 | 3.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.5 | 2.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.5 | 1.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.5 | 1.6 | GO:0030976 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) thiamine pyrophosphate binding(GO:0030976) |
0.5 | 2.2 | GO:0016887 | ATPase activity(GO:0016887) |
0.5 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 1.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.5 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 8.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.5 | 2.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 1.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 1.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.5 | 1.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.5 | 1.5 | GO:0005549 | odorant binding(GO:0005549) |
0.5 | 1.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.5 | 4.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 3.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 4.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 123.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.5 | 24.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.5 | 1.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.5 | 2.9 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.5 | 6.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 2.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 1.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.5 | 7.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 5.1 | GO:0005506 | iron ion binding(GO:0005506) |
0.5 | 2.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 3.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 9.9 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.4 | 4.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.4 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.4 | 3.4 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.4 | 1.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 1.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.4 | 296.1 | GO:0005488 | binding(GO:0005488) |
0.4 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 186.7 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.3 | 0.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.3 | 35.5 | GO:0016787 | hydrolase activity(GO:0016787) |
0.3 | 2.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 26.5 | GO:0005215 | transporter activity(GO:0005215) |
0.2 | 9.8 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.1 | 0.3 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 6.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.2 | GO:0030234 | enzyme regulator activity(GO:0030234) |
0.0 | 0.0 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 60.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
4.2 | 8.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
3.8 | 7.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
3.6 | 35.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.4 | 200.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
3.3 | 79.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
3.3 | 39.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
3.2 | 70.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
3.2 | 31.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
3.0 | 8.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
2.9 | 23.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.8 | 76.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.7 | 85.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
2.6 | 18.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.4 | 9.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.3 | 35.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
2.3 | 11.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
2.3 | 84.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.3 | 31.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.3 | 4.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.2 | 37.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.2 | 58.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.2 | 13.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.2 | 32.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
2.1 | 64.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.1 | 40.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.1 | 28.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.0 | 47.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.0 | 36.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
2.0 | 34.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
2.0 | 14.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
2.0 | 17.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.0 | 27.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.0 | 15.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.9 | 65.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.9 | 9.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.9 | 34.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.9 | 13.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.9 | 13.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.8 | 73.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.8 | 44.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.7 | 10.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.7 | 5.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.7 | 19.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.7 | 55.7 | PID LKB1 PATHWAY | LKB1 signaling events |
1.7 | 35.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.7 | 5.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.7 | 41.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.6 | 21.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.6 | 6.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.6 | 38.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.6 | 28.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.6 | 69.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.6 | 18.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.6 | 25.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.6 | 40.5 | PID FGF PATHWAY | FGF signaling pathway |
1.5 | 20.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.5 | 78.4 | PID P73PATHWAY | p73 transcription factor network |
1.5 | 10.8 | PID IFNG PATHWAY | IFN-gamma pathway |
1.5 | 6.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.5 | 19.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.5 | 6.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.5 | 27.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.5 | 34.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.5 | 21.0 | PID BCR 5PATHWAY | BCR signaling pathway |
1.5 | 22.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.5 | 22.3 | PID ARF6 PATHWAY | Arf6 signaling events |
1.5 | 25.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.5 | 22.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.5 | 2.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.4 | 20.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.4 | 41.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.4 | 4.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.4 | 15.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.4 | 2.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.4 | 12.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.4 | 1.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.4 | 4.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
1.4 | 19.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.3 | 30.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.3 | 28.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.3 | 3.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.3 | 3.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.3 | 7.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.3 | 16.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.3 | 2.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.3 | 5.1 | PID ENDOTHELIN PATHWAY | Endothelins |
1.3 | 21.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.3 | 40.1 | PID BMP PATHWAY | BMP receptor signaling |
1.3 | 15.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.3 | 6.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.2 | 6.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.2 | 23.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.2 | 7.3 | PID CDC42 PATHWAY | CDC42 signaling events |
1.2 | 68.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
1.2 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.2 | 50.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.2 | 58.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.2 | 19.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.2 | 19.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.1 | 14.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.1 | 26.3 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.1 | 20.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.1 | 6.6 | PID FOXO PATHWAY | FoxO family signaling |
1.1 | 12.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 22.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.1 | 9.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.1 | 10.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.0 | 9.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.0 | 8.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 4.1 | PID ALK2 PATHWAY | ALK2 signaling events |
1.0 | 7.2 | PID MYC PATHWAY | C-MYC pathway |
1.0 | 27.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.0 | 30.2 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 11.6 | PID RHOA PATHWAY | RhoA signaling pathway |
1.0 | 3.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.9 | 4.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.9 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 11.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.9 | 17.5 | PID ATM PATHWAY | ATM pathway |
0.9 | 4.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.9 | 3.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 8.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.9 | 3.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 6.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.9 | 28.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 2.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.8 | 2.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 10.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 16.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.8 | 21.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.8 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 14.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 4.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 1.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 7.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.8 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.8 | 3.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.8 | 6.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 11.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 5.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.7 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 118.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 3.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.7 | 5.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 7.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 8.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.7 | 4.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 1.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 5.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.6 | 10.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 14.0 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 10.1 | PID ATR PATHWAY | ATR signaling pathway |
0.6 | 5.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 3.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 5.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 8.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.6 | 11.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.6 | 117.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 2.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 14.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 2.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 1.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 9.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 9.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 8.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 5.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 3.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 3.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 6.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 2.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 34.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 6.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
5.5 | 66.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.0 | 4.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
4.0 | 32.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
3.7 | 14.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
3.6 | 39.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
3.5 | 108.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
3.4 | 27.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
3.1 | 24.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.0 | 9.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
3.0 | 29.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
3.0 | 8.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.9 | 54.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.8 | 36.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.8 | 36.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.7 | 11.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.7 | 8.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
2.7 | 8.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
2.6 | 21.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.6 | 2.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.6 | 12.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.5 | 70.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.5 | 78.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.5 | 5.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
2.4 | 9.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
2.4 | 12.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.4 | 31.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.4 | 26.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
2.4 | 49.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.3 | 18.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.2 | 22.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.2 | 77.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
2.2 | 32.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.2 | 32.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
2.1 | 38.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
2.1 | 23.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.1 | 48.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
2.1 | 2.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
2.0 | 12.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
2.0 | 67.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
2.0 | 36.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.0 | 6.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
2.0 | 28.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
2.0 | 20.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.0 | 83.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.0 | 27.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
2.0 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
2.0 | 15.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
2.0 | 3.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
2.0 | 23.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.9 | 11.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.9 | 25.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.9 | 65.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.9 | 15.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.9 | 1.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.9 | 11.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.9 | 5.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.9 | 35.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.9 | 11.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.9 | 37.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.8 | 16.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
1.8 | 100.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.8 | 20.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.8 | 3.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.8 | 12.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.8 | 5.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
1.8 | 5.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.7 | 29.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.7 | 25.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.7 | 1.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.7 | 36.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.7 | 6.8 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.7 | 20.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.7 | 25.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.7 | 50.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.7 | 28.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.7 | 26.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.6 | 3.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.6 | 17.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.6 | 33.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.6 | 9.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.6 | 18.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.5 | 29.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.5 | 26.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.5 | 13.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.5 | 22.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.5 | 45.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.5 | 12.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.5 | 46.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
1.5 | 8.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.5 | 22.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
1.5 | 25.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.5 | 5.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.5 | 10.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.4 | 8.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.4 | 15.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.4 | 4.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.4 | 4.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.4 | 12.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
1.4 | 15.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.4 | 19.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
1.4 | 9.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.4 | 15.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.4 | 30.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.4 | 20.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.3 | 20.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
1.3 | 16.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.3 | 2.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.3 | 18.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.3 | 22.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 19.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.3 | 1.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.3 | 5.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.3 | 2.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.3 | 7.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.3 | 2.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.3 | 18.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.3 | 33.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.2 | 19.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.2 | 81.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.2 | 15.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.2 | 6.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.2 | 23.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.2 | 16.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.2 | 2.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.2 | 10.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.2 | 30.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.2 | 20.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.2 | 18.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.2 | 9.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.2 | 10.6 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
1.2 | 7.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.2 | 3.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.2 | 10.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.2 | 6.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.1 | 10.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.1 | 12.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.1 | 12.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.1 | 75.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
1.1 | 2.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.1 | 10.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 1.1 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
1.1 | 9.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.1 | 3.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.1 | 85.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
1.1 | 35.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.1 | 4.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
1.1 | 73.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.1 | 15.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.1 | 18.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
1.1 | 16.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.1 | 25.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
1.1 | 23.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.1 | 52.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.0 | 3.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.0 | 12.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.0 | 29.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.0 | 12.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.0 | 29.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.0 | 56.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.0 | 85.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.0 | 2.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.0 | 96.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.0 | 1.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
1.0 | 3.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.0 | 15.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.0 | 1.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
1.0 | 42.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 10.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.0 | 4.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.0 | 2.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.0 | 8.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.0 | 6.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 7.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.9 | 38.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.9 | 8.5 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.9 | 2.8 | REACTOME S PHASE | Genes involved in S Phase |
0.9 | 18.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.9 | 6.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.9 | 5.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.9 | 8.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.9 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.9 | 16.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.9 | 212.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.9 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.9 | 4.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.9 | 8.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.9 | 32.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.9 | 13.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 8.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.9 | 47.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.9 | 1.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.8 | 11.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 27.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.8 | 17.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 12.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.8 | 53.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.8 | 70.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.8 | 23.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 8.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.8 | 10.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.8 | 10.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.8 | 13.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 30.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.8 | 13.4 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.8 | 11.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.8 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.8 | 11.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.8 | 9.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.8 | 16.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.8 | 11.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.8 | 85.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 5.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.8 | 13.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.8 | 17.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 9.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.8 | 6.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 22.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.8 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 20.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 0.7 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.7 | 32.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.7 | 6.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.7 | 5.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.7 | 33.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.7 | 27.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.7 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 5.7 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.7 | 9.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 68.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.7 | 6.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.7 | 4.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.7 | 13.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.7 | 18.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 0.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.7 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 6.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 0.6 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.6 | 5.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.6 | 23.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 1.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 5.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 6.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.6 | 7.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 4.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 14.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.6 | 6.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 7.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 8.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.6 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 18.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 5.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 10.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.5 | 26.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 10.9 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.5 | 1.0 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.5 | 6.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 4.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.5 | 7.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 5.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 5.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 6.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 6.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 4.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 14.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.4 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 1.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 4.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 21.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.4 | 0.4 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.4 | 4.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 0.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.4 | 10.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 10.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 6.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 9.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.4 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 4.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 0.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 1.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 7.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 2.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 4.5 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.3 | 6.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 7.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 7.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 4.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 1.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 3.0 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.3 | 6.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.3 | 2.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 2.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 3.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 3.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 2.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 21.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.0 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |